<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26831464</article-id><article-id pub-id-type="pmc">4735524</article-id><article-id pub-id-type="pii">srep20050</article-id><article-id pub-id-type="doi">10.1038/srep20050</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Gene profiling of embryonic skeletal muscle lacking type I ryanodine receptor Ca<sup>2+</sup> release channel</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Filipova</surname><given-names>Dilyana</given-names></name><xref ref-type="aff" rid="a1">1</xref><xref ref-type="author-notes" rid="n1">*</xref></contrib><contrib contrib-type="author"><name><surname>Walter</surname><given-names>Anna M.</given-names></name><xref ref-type="aff" rid="a1">1</xref><xref ref-type="author-notes" rid="n1">*</xref></contrib><contrib contrib-type="author"><name><surname>Gaspar</surname><given-names>John A.</given-names></name><xref ref-type="aff" rid="a2">2</xref></contrib><contrib contrib-type="author"><name><surname>Brunn</surname><given-names>Anna</given-names></name><xref ref-type="aff" rid="a3">3</xref></contrib><contrib contrib-type="author"><name><surname>Linde</surname><given-names>Nina F.</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Ardestani</surname><given-names>Mostafa A.</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Deckert</surname><given-names>Martina</given-names></name><xref ref-type="aff" rid="a3">3</xref></contrib><contrib contrib-type="author"><name><surname>Hescheler</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type="aff" rid="a2">2</xref></contrib><contrib contrib-type="author"><name><surname>Pfitzer</surname><given-names>Gabriele</given-names></name><xref ref-type="aff" rid="a1">1</xref></contrib><contrib contrib-type="author"><name><surname>Sachinidis</surname><given-names>Agapios</given-names></name><xref ref-type="aff" rid="a2">2</xref></contrib><contrib contrib-type="author"><name><surname>Papadopoulos</surname><given-names>Symeon</given-names></name><xref ref-type="corresp" rid="c1">a</xref><xref ref-type="aff" rid="a1">1</xref></contrib><aff id="a1"><label>1</label><institution>Center of Physiology and Pathophysiology, Institute of Vegetative Physiology, Medical Faculty of the University of Cologne</institution>, Robert-Koch-Str. 39, Cologne 50931, <country>Germany</country></aff><aff id="a2"><label>2</label><institution>Center of Physiology and Pathophysiology, Institute of Neurophysiology, Medical Faculty of the University of Cologne</institution>, Robert-Koch-Str. 39, Cologne 50931, <country>Germany</country></aff><aff id="a3"><label>3</label><institution>Department of Neuropathology, University Hospital of Cologne</institution>, Cologne, <country>Germany</country></aff></contrib-group><author-notes><corresp id="c1"><label>a</label><email>spapadop@uni-koeln.de</email></corresp><fn id="n1"><label>*</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>01</day><month>02</month><year>2016</year></pub-date><pub-date pub-type="collection"><year>2016</year></pub-date><volume>6</volume><elocation-id>20050</elocation-id><history><date date-type="received"><day>10</day><month>09</month><year>2015</year></date><date date-type="accepted"><day>22</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016, Macmillan Publishers Limited</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Macmillan Publishers Limited</copyright-holder><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><!--author-paid--><license-p>This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article&#x02019;s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link></license-p></license></permissions><abstract><p>In mature skeletal muscle, the intracellular Ca<sup>2+</sup> concentration rises dramatically upon membrane depolarization, constituting the link between excitation and contraction. This process requires Ca<sup>2+</sup> release from the sarcoplasmic reticulum via the type 1 ryanodine receptor (RYR1). However, RYR1&#x02019;s potential roles in muscle development remain obscure. We used an established RyR1- null mouse model, <italic>dyspedic</italic>, to investigate the effects of the absence of a functional RYR1 and, consequently, the lack of RyR1-mediated Ca<sup>2+</sup> signaling, during embryogenesis. Homozygous dyspedic mice die after birth and display small limbs and abnormal skeletal muscle organization. Skeletal muscles from front and hind limbs of dyspedic fetuses (day E18.5) were subjected to microarray analyses, revealing 318 differentially expressed genes. We observed altered expression of multiple transcription factors and members of key signaling pathways. Differential regulation was also observed for genes encoding contractile as well as muscle-specific structural proteins. Additional qRT-PCR analysis revealed altered mRNA levels of the canonical muscle regulatory factors <italic>Six1, Six4, Pax7, MyoD, MyoG</italic> and <italic>MRF4</italic> in mutant muscle, which is in line with the severe developmental retardation seen in dyspedic muscle histology analyses. Taken together, these findings suggest an important non-contractile role of RyR1 or RYR1-mediated Ca<sup>2+</sup> signaling during muscle organ development.</p></abstract></article-meta></front><body><p>Calcium is a key factor in a plethora of signaling pathways and cellular processes, including differentiation, growth, apoptosis, metabolism and transcriptional regulation. In developing skeletal muscle Ca<sup>2+</sup> is required for myoblast migration, fusion and terminal differentiation, and for muscle growth<xref ref-type="bibr" rid="b1">1</xref><xref ref-type="bibr" rid="b2">2</xref>. Beyond this, Ca<sup>2+</sup> is an essential regulator of muscle contraction<xref ref-type="bibr" rid="b3">3</xref>.</p><p>An important reservoir for changes in cytosolic calcium, [Ca<sup>2+</sup>]<sub>i</sub>, and by far the dominating source in differentiated skeletal muscle, is the sarcoplasmic reticulum (SR). The two most important Ca<sup>2+</sup> channels for Ca<sup>2+</sup> release from the internal stores during skeletal muscle development and differentiation appear to be the inositol 1,4,5<italic>-</italic>trisphosphate receptor (IP3R) and the type 1 ryanodine receptor (RyR1). On the basis of the kinetics of [Ca<sup>2+</sup>]<sub>i</sub> transients, these two channels have been assigned slow (IP3R) and fast (RyR1) Ca<sup>2+</sup> transients, respectively<xref ref-type="bibr" rid="b4">4</xref>. The fast Ca<sup>2+</sup> transients are the typical stimulus for triggering muscle contraction via excitation-contraction coupling (ECC). In contrast to the fast mechanism, the slow Ca<sup>2+</sup> transients consist of two kinetically discernible components, both characterized by subthreshold Ca<sup>2+</sup> levels with respect to initiation of contraction. However, it has been demonstrated that the faster of the two slow components, termed &#x0201c;slow-rapid&#x0201d;, is also mediated by RyR1 and is prominent in both cytoplasm and nucleus, whereas the second, termed &#x0201c;slow-slow&#x0201d; is confined to the nucleus<xref ref-type="bibr" rid="b5">5</xref> and is generated by Ca<sup>2+</sup> release through the IP3R, which localizes to the nuclear envelope and also to distinct, extra-junctional regions of the SR<xref ref-type="bibr" rid="b6">6</xref><xref ref-type="bibr" rid="b7">7</xref>. Slow [Ca<sup>2+</sup>]<sub>i</sub> kinetics have been linked to signaling<xref ref-type="bibr" rid="b5">5</xref> via activation of the nuclear factor kappa B (NF&#x003ba;B) as well as the mitogen-activated protein kinase (MAPK) pathway through ERK1/2, CREB, and the early response genes <italic>c-Jun</italic> and <italic>c-Fos</italic>, in response to depolarization and to other stimuli like reactive oxygen species (ROS) and hormones, like insulin, for instance<xref ref-type="bibr" rid="b8">8</xref><xref ref-type="bibr" rid="b9">9</xref><xref ref-type="bibr" rid="b10">10</xref>. Thus, a crucial role of slow Ca<sup>2+</sup> transients in muscle cells for downstream gene expression, and its relevance for skeletal muscle adaptation, becomes apparent. Different models, ranging from the C2C12 muscle cell line, primary muscle cell cultures at different differentiation states, to mouse muscle fibers, have been used to investigate the effects of [Ca<sup>2+</sup>]<sub>i</sub> dynamics on gene expression. The usage of these diverse models has occasionally led to differing conclusions about the relative relevance of IP3R and RyR1-mediated Ca<sup>2+</sup> release. However, even when using the same model the observations can occasionally differ, probably due to differences in experimental setup and conditions<xref ref-type="bibr" rid="b11">11</xref>. Currently, the relevance and the relative contribution of RyR1-mediated Ca<sup>2+</sup> release in gene regulation during myogenesis and muscle differentiation is not clear.</p><p>The dyspedic mouse model, a RYR1-null mutant, has proven as a valuable model system for the investigation of ECC in skeletal muscle<xref ref-type="bibr" rid="b12">12</xref><xref ref-type="bibr" rid="b13">13</xref>. While heterozygous mice of the model are functionally indistinguishable from wild type (WT) littermates, homozygous dyspedic mice (referred to as <italic>dysp</italic> in the sequel) die at birth from asphyxia, due to paralysis of skeletal muscle including the diaphragm. Furthermore, homozygous mice are characterized by an abnormal spine curvature, subcutaneous hematomas, enlarged neck and small limbs<xref ref-type="bibr" rid="b12">12</xref>. The latter implicates a dysregulation of embryonic myogenesis in the <italic>dysp</italic> mutant. While a similar phenotype is reproduced by a mouse model carrying the central core disease mutation RyR1<sup>I4895T</sup>, which renders the RyR1 channel non-functional in terms of Ca<sup>2+</sup> release<xref ref-type="bibr" rid="b14">14</xref>, no study has so far investigated the transcriptomic consequences of the lack of RyR1-mediated Ca<sup>2+</sup> signaling during skeletal myogenesis. In order to elucidate manifested differences between <italic>dysp</italic> fetuses and their heterozygous control littermates, we used animals at stage E18.5. In addition to a macroscopic and microscopic morphology analysis, we extracted mRNA from front and hind limb muscles of four <italic>dysp</italic> and four control fetuses, and subjected it to microarray analyses (total of 8 microarrays). We identified more than 300 differentially expressed genes (DEGs), the expression of which was decreased or increased by at least 1.5-fold in <italic>dysp</italic> compared to their control littermates. Our results reveal an extensive downregulation of multiple DEGs encoding structural and contractile muscle proteins, and indicate alterations in extracellular matrix (ECM) composition. Moreover, the absence of the RYR1 protein and, consequently, RYR1-mediated Ca<sup>2+</sup> release, in <italic>dysp</italic> muscle resulted in the transcriptional dysregulation of multiple members of major signaling networks like the MAPK pathway, the Wnt signaling pathway and the PI3K/AKT/mTOR pathway. A further analysis revealed significant differences in the mRNA levels of the key myogenic factors Six1, Six4, Pax7, MyoD, MyoG and Mrf4, corroborating the genetic basis for the delay in myogenesis.</p><p>Thus, our studies of on <italic>dysp</italic> skeletal muscle reveal extensive alterations in the transcriptional regulation of numerous genes coding for structural, metabolic and regulatory proteins, suggesting that RYR1-mediated Ca<sup>2+</sup> release plays a pivotal role not only in muscle contraction, but also in the orchestration and coordination of skeletal muscle development and differentiation.</p><sec disp-level="1"><title>Results</title><sec disp-level="2"><title>Histological analysis of <italic>dysp</italic> limb skeletal muscle</title><p>The histology of E18.5 skeletal muscle from homozygous <italic>dysp</italic> mice displayed severe disorganization and showed indications for developmental retardation (<xref ref-type="fig" rid="f1">Fig. 1</xref>). In contrast to heterozygous mice of the same developmental stage, which had well developed muscles, organized in fascicles and covered by a fascia, skeletal muscle of <italic>dysp</italic> mice displayed only small groups of muscle cells, lacking organized fascicles and a fascia (<xref ref-type="fig" rid="f1">Fig. 1b,c</xref>).</p></sec><sec disp-level="2"><title>Microarray analysis of <italic>dysp</italic> limb skeletal muscle</title><p>In an attempt to elucidate the basis for the drastic phenotypic alterations observed in <italic>dysp</italic> skeletal muscle, we performed microarray analyses of the transcriptome of fore- and hind limb skeletal muscle from four <italic>dysp</italic> and four control mouse fetuses at E18.5. The analyses returned 45,101 hits (identified transcript sets), spanning 21,569 unique annotated genetic loci. After data normalization and subsequent statistical analysis (see Materials and Methods) we identified 417 genomic loci, the expression of which was significantly (FDR-adjusted P value&#x02009;&#x02264;&#x02009;0.05) positively or negatively regulated by at least 1.5-fold compared to the control (<xref ref-type="supplementary-material" rid="S1">Supplementary Table S1</xref>). Of these, 394 mapped within known genes and 23 mapped at non-annotated genomic positions. The 394 differentially expressed loci were matched to 318 unique differentially expressed transcripts, of which 159 were positively regulated and 159 were negatively regulated in <italic>dysp</italic> skeletal muscle.</p><p>The DEGs were classified into functional categories via the web-based Gene Ontology (GO) analysis tool <italic>DAVID</italic><xref ref-type="bibr" rid="b15">15</xref>, using the groupings <italic>biological process</italic>, <italic>cellular compartment</italic> and <italic>molecular function</italic> (<xref ref-type="fig" rid="f2">Fig. 2a,b</xref>; <xref ref-type="supplementary-material" rid="S1">Supplementary Table S2</xref>). The 10 most significantly regulated GO categories, enriched with downregulated DEGs (<xref ref-type="fig" rid="f2">Fig. 2a</xref>), contain multiple muscle-specific structures and processes, including <italic>myofibril</italic> (6 DEGs), <italic>contractile fiber</italic> (6 DEGs), <italic>I band</italic> (4 DEGs) and <italic>muscle organ development</italic> (6 DEGs). The GO enrichment analysis for upregulated DEGs (<xref ref-type="fig" rid="f2">Fig. 2b</xref>) identified the regulation of <italic>apoptosis/ programmed cell death</italic> (16 DEGs) as the most significantly regulated GO categories. Interestingly, both induction (6 DEGs) as well as negative regulation (7 DEGs) of apoptosis were solidly identified.</p><p>In order to gain a better understanding about which molecular functions might have been affected by the transcriptomic alternations in <italic>dysp</italic> muscle, the 318 identified DEGs were subjected to a gene enrichment analysis according to the <italic>KEGG, Reactome</italic> and <italic>Panther</italic> data bases (<xref ref-type="fig" rid="f2">Fig. 2c&#x02013;e</xref>)<xref ref-type="bibr" rid="b16">16</xref>. Some of the well represented molecular functions and processes across the examined data bases are focal adhesion, ECM organization, ECM-receptor interaction, collagen formation and, most interestingly, muscle and striated muscle contraction. The <italic>KEGG</italic> pathway analysis revealed the MAPK pathway as the most significantly affected pathway (<xref ref-type="fig" rid="f2">Fig. 2c</xref>). This pathway was also identified by the <italic>Reactome Pathways</italic> (<xref ref-type="fig" rid="f2">Fig. 2d</xref>) and the <italic>Panther</italic> data bases (<xref ref-type="fig" rid="f2">Fig. 2e</xref>), the latter detecting also the p38 and IGF-I/MAPK/ERK cascades. Oxidative stress response, apoptosis and the p53 pathway, well known for their connection to (and regulation by) the MAPK pathway, have also been listed by the <italic>Panther</italic> data base enrichment analysis<xref ref-type="bibr" rid="b17">17</xref><xref ref-type="bibr" rid="b18">18</xref><xref ref-type="bibr" rid="b19">19</xref>.</p></sec><sec disp-level="2"><title>Validation of the microarray data via principal component analysis (PCA) and via qRT-PCR</title><p>In order to assess the variance between the <italic>dysp</italic> and control group, as well as between the biological replicates within each group, PCA was performed for all genes identified in the microarrays (<xref ref-type="fig" rid="f3">Fig. 3a</xref>, left) as well as for the subset of 318 DEGs with fold changes (FC) &#x02265; &#x000b1;1.5 and P values&#x02009;&#x02264;&#x02009;0.05 (<xref ref-type="fig" rid="f3">Fig. 3a</xref>, right). Each spot in <xref ref-type="fig" rid="f3">Fig. 3a</xref> represents one biological replicate. The PCA plot generated for all transcripts shows a clear grouping of the <italic>dysp</italic> and control samples. The PCA plot generated for the 318 DEGs demonstrates a strong correlation between the intra-group replicates (<italic>dysp</italic> vs. <italic>dysp</italic>; control vs. control) compared to inter-group replicates(<italic>dysp</italic> vs. control), as the principal component (PC) 1 is showing a 87.2% variance while in PC 2 this value only amounts to 4.9%. A heat map representation of the 318 DEGs of each biological replicate is shown in (<xref ref-type="fig" rid="f3">Fig. 3b</xref>).</p><p>Selected genes, for which our microarray analyses had reported changes in their expression, were validated via real-time quantitative PCR (qRT-PCR). The genes chosen include both downregulated (<xref ref-type="fig" rid="f3">Fig. 3c</xref>) as well as upregulated (<xref ref-type="fig" rid="f3">Fig. 3d</xref>) species, with strong as well as weak fold changes (FC). For all of the analyzed DEGs, qRT-PCR results confirmed our microarray data with respect to both, direction of change (up- or downregulation) and degree of change in expression, FC.</p></sec><sec disp-level="2"><title>Transcripts displaying the highest fold-changes in <italic>dysp</italic> skeletal muscle</title><p>The ten genes with the highest fold-change (in positive as well as in negative direction) we found in our microarray analysis are shown in <xref ref-type="table" rid="t1">Table 1</xref>. Highest induction (6.5-fold) was observed for collagen type XXV alpha 1 (<italic>Col25a1</italic>) and similarly for another collagen, type XIX alpha 1 (<italic>Col19a1</italic>), implicated in early myogenesis<xref ref-type="bibr" rid="b20">20</xref>. Among the downregulated genes in <italic>dysp</italic> muscle, the gene encoding myosin light chain 2 (<italic>Myl2</italic>) showed the lowest expression rate (&#x02212;10.8-fold). <xref ref-type="table" rid="t1">Table 1</xref> also lists several other important genes, associated with muscle structure and function, like <italic>Tppp3</italic>, <italic>Irf6</italic> and <italic>Cnn1</italic>. These latter genes were negatively regulated to a high degree (<xref ref-type="table" rid="t1">Table 1</xref>).</p></sec><sec disp-level="2"><title>Signaling pathways enriched with DEGs in <italic>dysp</italic> skeletal muscle</title><p>Our analysis identified several major signaling pathways as being substantially enriched with DEGs. In particular, the MAPK pathway is represented with 21 DEGs, encoding proteins involved at different stages of Ras, JNK and p38 signaling (<xref ref-type="table" rid="t2">Table 2</xref>), 7 of which are positively and 14 negatively regulated. Interestingly, the majority of downregulated DEGs encode proteins that engage late downstream in the pathway, like the FBJ osteosarcoma oncogene (<italic>c-Fos</italic>), the Jun oncogene (<italic>c-Jun</italic>), the Jun proto-oncogene related gene D (<italic>Jund</italic>) and the calcineurin dependent nuclear factor of activated T cells 2 (<italic>Nfatc2</italic>). These genes encode global transcription factors that regulate transcription in response to various stimuli, modulating a variety of cellular responses and processes, including proliferation, differentiation, inflammation and apoptosis. Notably, the <italic>c-Fos, c-Jun</italic> and <italic>Jund</italic> genes all encode different dimerization partners within the composition of the pleiotropic transcription factor activating protein-1 (AP-1). Another interesting finding is that several DEGs encoding cell surface receptor proteins like the neurotrophic tyrosine kinase receptor type 2 (<italic>Ntrk2</italic>), the transforming growth factor beta receptor I (<italic>Tgfbr1</italic>), as well as the beta 4 subunit of voltage-dependent calcium channels (<italic>Cacnb4</italic>), all linked to the MAPK pathway, were upregulated. We observed a negative regulation of four dual specificity phosphatase transcripts (<italic>Dusp1, Dusp8, Dusp10 and Dusp16</italic>), as well as the heat shock protein 1-like (<italic>Hspa1l</italic>) gene, all of which inactivate ERK, JNK or p38. Additionally, among the DEGs of the MAPK pathway, there are several genes encoding key proteins connecting multiple signaling pathways. For example, the thymoma viral proto-oncogene 2 (<italic>Akt2</italic>), found to be positively regulated by our microarray analyses, encodes a central member of the PI3K/Akt/mTOR pathway, also represented with several other DEGs, including the Akt&#x02019;s activator, the p85 alpha regulatory subunit of the phosphatidylinositol 3-kinase (<italic>Pik3r1</italic>) and Akt&#x02019;s target, the gene encoding the cyclin-dependent kinase inhibitor 1A (P21) (<italic>Cdkn1a</italic>). 10 DEGs are associated with the Wnt signaling pathway, including the downregulated genes wingless-related MMTV integration site 2 (<italic>Wnt2</italic>), secreted frizzled-related protein 4 (<italic>Sfrp4</italic>) and the induced transcript 1 of transforming growth factor beta 1 (<italic>Tgfb1i1</italic>), as well as secreted frizzled-related protein 1 (<italic>Sfrp1</italic>), one of the few positively regulated transcripts in this pathway. Many of the identified DEGs encode G protein coupled receptors (GPCRs) or modulators of GPCR-mediated signaling, as well as various transcription factors. Thus, the microarray analysis indicates substantial changes in the expression profile of global signaling networks. Several of the DEGs involved in ubiquitous signaling pathways have been previously linked to muscular processes and are described later in this manuscript in the context to of muscle development and function.</p></sec><sec disp-level="2"><title>Muscle specific processes enriched with DEGs in <italic>dysp</italic> skeletal muscle</title><p>Enrichment analyses (<xref ref-type="fig" rid="f2">Fig. 2</xref>) revealed a strong change in the transcription levels of genes involved in muscle contraction as well as in processes like focal adhesion, ECM organization, ECM-receptor interaction and collagen matrix formation. These processes are intimately linked to the development and morphogenic structure of the skeletal muscle organ. In order to further analyze which of the 318 DEGs are particularly involved in processes related to muscle development and function, we applied the online enrichment tools <italic>DAVID GO, Panther GO and MGI GO</italic>, combined with manual data mining. In doing so, we identified 21 genes (16 downregulated and 5 upregulated) unambiguously related to muscle force production and to the components of the contraction apparatus (<xref ref-type="table" rid="t3">Table 3</xref> a). Specifically, these genes encode sarcomeric and costameric proteins, as well as proteins involved in excitation-dependent processes.</p><p>We furthermore identified 22 genes (14 downregulated and 8 upregulated) related to mostly structural features of the muscle organ, comprising proteins of the extracellular matrix, the cytoskeleton and transmembrane/cell-surface proteins (<xref ref-type="table" rid="t3">Table 3</xref> b).</p></sec><sec disp-level="2"><title>Altered expression of myogenic regulatory factors in <italic>dysp</italic> skeletal muscle</title><p>Proper embryonic development of skeletal muscle is governed by both intrinsic and extrinsic mechanisms<xref ref-type="bibr" rid="b21">21</xref>. Among the most important intrinsic signals controlling myogenesis progression are the transcription factors Six1, Six4, Pax3, Pax7, MyoD, MyoG and Mrf4. Each of these is expressed in a specific population of cells from the myogenic lineage and has a discrete temporal expression pattern during myogenesis. While none of these factors passed our stringent threshold for being classified as significantly regulated (FC &#x02265; &#x000b1;1.5, FDR-adjusted P value&#x02009;&#x02264;&#x02009;0.05), the microarrays indicated changes in the expression levels of <italic>Six4</italic> (FC&#x02009;=&#x02009;1.38, P&#x02009;=&#x02009;0.0027), <italic>Pax7</italic> (FC&#x02009;=&#x02009;1.27, P&#x02009;=&#x02009;0.0074), <italic>Myf5</italic> (FC&#x02009;=&#x02009;1.25, P&#x02009;=&#x02009;0.04), <italic>MyoD</italic> (FC&#x02009;=&#x02009;1.53, P&#x02009;=&#x02009;0.0018) and <italic>MyoG</italic> (FC&#x02009;=&#x02009;1.46, P&#x02009;=&#x02009;0.0001) (<xref ref-type="fig" rid="f4">Fig. 4</xref>). Moreover, the severe <italic>dysp</italic> histology shown in <xref ref-type="fig" rid="f1">Fig. 1</xref> suggested developmental defects, prompting us to closer examine the relative expression levels of these important developmental markers. qRT-PCR analysis revealed a significant (P&#x02009;&#x02264;&#x02009;0.05) upregulation in the expression of <italic>Six1, Six4, Pax7, MyoD, MyoG and Mrf4</italic> in <italic>dysp</italic> muscle, with FCs 1.27&#x02009;&#x000b1;&#x02009;0.07 (P&#x02009;=&#x02009;0.0138) for <italic>Six1</italic>; 1.66&#x02009;&#x000b1;&#x02009;0.19 (P&#x02009;=&#x02009;0.0136) for <italic>Six4</italic>; 1.57&#x02009;&#x000b1;&#x02009;0.18 (P&#x02009;=&#x02009;0.0183) for <italic>Pax7</italic>; 2.39&#x02009;&#x000b1;&#x02009;0.30 (P&#x02009;=&#x02009;0.0049) for <italic>MyoD</italic>; 1.97&#x02009;&#x000b1;&#x02009;0.18 (P&#x02009;=&#x02009;0.0022) for <italic>MyoG</italic> and 1.51&#x02009;&#x000b1;&#x02009;0.19 (P&#x02009;=&#x02009;0.0343) for <italic>MRF4</italic> (<xref ref-type="fig" rid="f4">Fig. 4</xref>). The increased transcript levels of myogenic markers in E18.5 dysgenic muscle are in line with the presence of a delay in myogenesis<xref ref-type="bibr" rid="b21">21</xref>.</p></sec></sec><sec disp-level="1"><title>Discussion</title><p>The RYR1 Ca<sup>2+</sup> release channel is a major component of the ECC apparatus in skeletal muscle and various mutations in its gene have been associated with a number of muscular disorders including malignant hyperthermia and several congenital myopathies<xref ref-type="bibr" rid="b22">22</xref>. The absence of RYR1 in homozygous <italic>dysp</italic> mice leads to excitation-contraction uncoupling and perinatal lethality, accompanied by abnormal alterations in muscle phenotype, indicative of impaired muscle development<xref ref-type="bibr" rid="b12">12</xref>. The goal of this study was to identify signaling pathways and biological processes influenced by RYR1 during skeletal muscle formation, at late stages of embryonic development. For this purpose, we performed a microarray analysis of limb skeletal muscle from <italic>dysp</italic> fetuses and their control litter mates at day E18.5. This approach led to the identification of more than 300 differentially expressed genes.</p><p><italic>Dysp</italic> muscle lacks both, Ca<sup>2+</sup> release for mechanical movement and RyR1-mediated Ca<sup>2+</sup> signaling. It is likely the combination of both, ablation of mechanotransduction and of RyR1 dependent Ca<sup>2+</sup> signaling, which leads to the severe phenotype of E18.5 <italic>dysp</italic> muscle. Although our data refer to embryonic muscle, we find parallels in the direction of transcriptional changes to animal models for acute denervation, amyotrophic lateral sclerosis (ALS) or toxin-induced paralysis. For instance, in <italic>dysp</italic> skeletal muscle we observe mRNA upregulation for the transcription factor Runx1, which has been implicated in the counteraction of muscle wasting, autophagy and myofibrillar disorganization<xref ref-type="bibr" rid="b23">23</xref><xref ref-type="bibr" rid="b24">24</xref>. Classically, we observe an upregulation of the acetylcholine receptor &#x003b1; (<italic>Chrna1</italic>) as well as the fetal &#x003b3; subunit (<italic>Chrng</italic>)<xref ref-type="bibr" rid="b25">25</xref>, and of the acetylcholine receptor-associated protein of the synapse (<italic>Rapsn</italic>)<xref ref-type="bibr" rid="b26">26</xref>. Furthermore we see a downregulation for the ECM transcripts tenascin C (<italic>Tnc</italic>) and microfibrillar associated protein 5 (<italic>Mfap5</italic>)<xref ref-type="bibr" rid="b27">27</xref><xref ref-type="bibr" rid="b28">28</xref> as well as a strong upregulation for collagen type XIX&#x003b1;1 (<italic>Col19a1</italic>), which has also been found to be upregulated in ALS muscle<xref ref-type="bibr" rid="b29">29</xref>.</p><p>However, some transcriptional changes in the <italic>dysp</italic> model contrast those seen in models for paralysis and denervation. For <italic>Ankrd1</italic>, a member of the titin-N2A mechanosensory complex of the Z-disc<xref ref-type="bibr" rid="b30">30</xref> with roles in muscle morphogenesis and remodeling, we find a strong downregulation, whereas an upregulation was observed in ALS muscle and after denervation<xref ref-type="bibr" rid="b23">23</xref><xref ref-type="bibr" rid="b29">29</xref> [noticeably, no <italic>Ankdr1</italic> at all was detected in a study of central core disease (CCD) in humans, a disease linked to deficient function of RyR1 Ca<sup>2+</sup> release<xref ref-type="bibr" rid="b31">31</xref>]. The <italic>Tnfrs12a</italic> transcript, coding for the Tweak receptor, was shown to be upregulated upon denervation<xref ref-type="bibr" rid="b32">32</xref> but we find it downregulated in <italic>dysp</italic> skeletal muscle. Both, Tweak and Ankrd1 are Bcl-3 targets and represent repression targets of p38&#x003b3;<xref ref-type="bibr" rid="b33">33</xref> (discussed below).</p><p>Interestingly, the &#x0201c;resting&#x0201d; [Ca<sup>2+</sup>]<sub>i</sub> is ~2-fold lower in <italic>dysp</italic> compared to WT myotubes<xref ref-type="bibr" rid="b34">34</xref>. This already could have effects on Ca<sup>2+</sup> dependent signaling. The consistent downregulation of <italic>c-Fos</italic>, <italic>c-Jun</italic>, <italic>Jund</italic> and <italic>Nfatc2</italic>, encoding phosphorylation targets of ERK1/2, JNK and p38, could imply a disturbed regulation of these central MAPKs, which are activated in a Ca<sup>2+</sup>-dependent manner<xref ref-type="bibr" rid="b35">35</xref><xref ref-type="bibr" rid="b36">36</xref> (however, in intact muscle, all of the latter would be activated by mechanical stress as well and could exert their important roles in myogenesis<xref ref-type="bibr" rid="b37">37</xref>). We identified a number of DEGs, which, in the context of metabolic adaptation to exercise, are influenced by p38&#x003b3;<xref ref-type="bibr" rid="b33">33</xref>. Thus, altered p38y activity in <italic>dysp</italic> muscle could affect oxidative metabolism. This notion is supported by the changes in transcription we see for various genes whose products take part in oxidative reactions, like the gene encoding methionine sulfoxide reductase B3 (<italic>Msrb3</italic>), or genes, the expression of which is regulated in response to oxidative stress, like thrombospondin 4 (<italic>Thbs4</italic>). The latter is expressed in red skeletal muscle, i.e. in fibers with high oxidative capacity<xref ref-type="bibr" rid="b38">38</xref>. However, we find it 2-fold downregulated in <italic>dysp</italic> skeletal muscle. Moreover, the expression of <italic>c-Jun</italic> and <italic>c-Fos</italic>, which has been shown to be positively regulated by oxidative stress in a RYR1-dependent manner<xref ref-type="bibr" rid="b9">9</xref>, is decreased in <italic>dysp</italic> muscle, indicating that the absence of RYR1 may also affect ROS-sensitive signaling cascades.</p><p>The formation of skeletal muscle is critically modulated by Wnt signaling<xref ref-type="bibr" rid="b39">39</xref>. Our results reveal a downregulation of Wnt signaling factors <italic>Wnt2, Cd44, Fzd10, Tgfb1i1</italic>, combined with the upregulation of <italic>Sfrp1</italic>, an inhibitor of Wnt signaling. Overall, in <italic>dysp</italic> muscle we see indications for a shift from canonical, pro-myogenic Wnt signaling to the less defined non-canonical pathway<xref ref-type="bibr" rid="b40">40</xref>. However, since non-canonical Wnt signaling can activate Ca<sup>2+</sup> release via IP3R, this shift might represent a compensatory attempt to raise [Ca<sup>2+</sup>]<sub>i</sub> in <italic>dysp</italic> myotubes. Moreover, the non-canonical pathway also appears to activate the Akt/mTOR pathway, involved in increased anabolic activity and in hypertrophy of skeletal muscle<xref ref-type="bibr" rid="b41">41</xref>. Accordingly, we observe an upregulation of the central (<italic>Pik3r1, Akt2</italic>) and late (<italic>Cdkn1a</italic>) stages of Akt/mTOR signaling.</p><p>Genes encoding structural proteins of muscle are also affected in <italic>dysp</italic> muscle. Previous studies indicated that the <italic>dysp</italic> skeletal muscle expresses the major elements of the triad junction<xref ref-type="bibr" rid="b12">12</xref><xref ref-type="bibr" rid="b42">42</xref>. However, the transcripts of many genes taking part in the formation, organization and structure of the muscle contractile apparatus (<italic>Myl2, Myl3, Myl9, Smtln1, Cnn1, Tpm3, Ankrd1, Nrap, Csrp3, Pdlim1, Fhl1, Nes</italic> and <italic>Tnnt2</italic>) are, with the exception of <italic>Tnnt2</italic>, negatively regulated (<xref ref-type="table" rid="t1">Table 1</xref>). Notably, many other negatively regulated DEGs (<italic>Ankrd1, Nrap, Csrp3, Pdlim1, Fhl1, Nes</italic>) encode proteins that localize to the Z disc of sarcomeres and some of them connect sarcomeres to the t-tubular system of the sarcolemma and to the SR. Although the above proteins are primarily known for their structural and contractile function, many of them also have important roles in mechanosensing and in signaling into gene expression<xref ref-type="bibr" rid="b43">43</xref> and myogenesis. Thus, absence of RYR1 affects different levels of muscle cell function.</p><p>We also find transcriptional changes in genes encoding extracellular matrix (ECM) proteins. <italic>Mfap5, Tnxb, Tnc, Fn1, Adamtsl4</italic> and <italic>Fbn1</italic> are involved in microfibrillar assembly and in matrix structuring, and their changes suggest an impaired elastic fiber formation<xref ref-type="bibr" rid="b44">44</xref><xref ref-type="bibr" rid="b45">45</xref><xref ref-type="bibr" rid="b46">46</xref><xref ref-type="bibr" rid="b47">47</xref>. Conversely, the expression level of three collagen species (<italic>Col20a1, Col19a1</italic> and <italic>Col25a1</italic>) is strongly upregulated in <italic>dysp</italic> muscle (<xref ref-type="table" rid="t1">Table 1</xref>). These changes may indicate a shift in the ECM composition towards collagen fibers at the expense of elastic fibers. Since mechanical loading is a critical stimulus in organization and turnover of ECM in skeletal muscle<xref ref-type="bibr" rid="b48">48</xref>, the immobilization in <italic>dysp</italic> skeletal muscle might contribute to the observed tissue disorganization (<xref ref-type="fig" rid="f1">Fig. 1b,c</xref>).</p><p>Although their extensive discussion is beyond the scope of our study, we should mention that genes associated with other important components or processes of skeletal muscle were also among the DEGs of <italic>dysp</italic> muscle, like satellite cells (<italic>Six1</italic>, <italic>Six4</italic>, <italic>Pax7</italic>, <italic>Sfrp4</italic>, <italic>Dusp10</italic>, <italic>Nes, Rgs5</italic>, <italic>Cav2</italic>, <italic>Megf10</italic>, <italic>Hgf</italic>, <italic>Ptpz1</italic>, <italic>Aif1</italic>, <italic>Cnr1</italic>), myoblast fusion and differentiation (<italic>Mfap5</italic>, <italic>Nov</italic>, <italic>Dpysl3</italic>, <italic>Wnt2</italic>, <italic>Cd44</italic>, <italic>Nfatc2</italic>, <italic>Cdkn1a</italic>, <italic>Hes6</italic>, <italic>Akt2</italic>, <italic>Adamtsl2</italic>, <italic>Hdac4</italic>, <italic>Fst</italic>, <italic>Sfrp1</italic>, <italic>Bai3</italic>, <italic>Marveld2</italic>), and terminal muscle differentiation (<italic>Myod</italic>, <italic>Myog</italic>, <italic>Mrf4</italic>, <italic>Hes6</italic>, <italic>Csrp3</italic>,<italic>Bcl6</italic>, <italic>Fgf6</italic>, <italic>Nfatc2</italic>) (<xref ref-type="supplementary-material" rid="S1">Supplementary Table 1</xref>). However, the observed upregulation of the canonical myogenic regulatory factors <italic>Six1, Six4, Pax7, MyoD, Myog</italic> and <italic>MRF4</italic>, the expression of all of which (except for <italic>MRF4</italic>) is attenuated in terminally differentiated, intact skeletal muscle<xref ref-type="bibr" rid="b21">21</xref>, already indicates that the virtually the entire developmental repertoire of myogenic factors is challenged in the <italic>dysp</italic> phenotype.</p><p>In conclusion, our report provides the first extensive skeletal muscle transcriptome analysis of the dyspedic mouse model, revealing that absence of the major Ca<sup>2+</sup> release channel, RyR1, introduces multilayered transcriptomic alterations in developing skeletal muscle. The differential expression of genes, encoding a multitude of signaling and structural proteins important for embryonic development, suggests a complex regulatory role for RYR1 in myogenesis. This is reflected by the severely disorganized and developmentally retarded skeletal muscle histology, documenting the severe consequences of RyR1 absence. Further studies will aim to elucidate the exact molecular mechanisms of RYR1-mediated regulation of muscle organ development.</p></sec><sec disp-level="1"><title>Methods</title><sec disp-level="2"><title>Animals and skeletal muscle preparation</title><p>Experiments with mice were carried out in accordance with the guidelines of the European Commission (Directive 2010/63/EU) and of the German animal welfare act (TierSchG). The mice were kept in the Animal Facility of the Medical Faculty of the University of Cologne according to the European Union Recommendation 2007/526/EG. All experimental protocols were approved by the local governmental authorities (Landesamt f&#x000fc;r Natur, Umwelt und Verbraucherschutz, North Rhine-Westphalia, AZ84-02.05.20.13.010). The dyspedic mouse line ry1<xref ref-type="bibr" rid="b42">42</xref> with the background C57BL/6J was obtained from Vincenzo Sorrentino, University of Siena, upon generous approval by Paul Allen, UC Davis. Two heterozygous <italic>dysp</italic> male and female mice were subjected to timed mating. The pregnant females were sacrificed at day 18.5 post coitum by cervical dislocation. Two homozygous <italic>dysp</italic> and two control-pup littermates (as confirmed by subsequent PCR) from each female were prepared as described previously<xref ref-type="bibr" rid="b49">49</xref> and used in the subsequent analyses (<xref ref-type="supplementary-material" rid="S1">Supplemental Fig. 1</xref>). Skeletal muscle was dissected from the front and hind limb of the pups, pooled for each animal, frozen and stored in liquid nitrogen until use. The samples from each animal were collected and treated separately for all subsequent analyses, yielding 4 biological replicates per group (<italic>dysp</italic> and control), respectively.</p></sec><sec disp-level="2"><title>Morphological analysis</title><p>To give an impression of how <italic>dysp</italic> fetuses present at E18.5 in comparison to their unaffected heterozygous littermates, the body shape and size was documented by photographs. Horizontal and longitudinal sections of the entire front and hind limbs of E18.5 weeks old <italic>dysp</italic> fetuses and their WT littermates were prepared and mounted on thick filter paper with Tissue Tek OCT compound (Miles Scientific, Naperville, IL), snap-frozen in isopentane (Fluka, Neu-Ulm, Germany) pre-cooled by dry ice, and stored at &#x02212;80&#x02009;&#x000b0;C until preparation of serial 10-&#x003bc;m frozen sections. Enzyme histochemistry was performed with reactions for myofibrillar ATPase at pH 9.4 and pH 4.6, acid phosphatase, oil red, and reduced nicotinamide adenine dinucleotide-tetrazolium reductase (NADH).</p></sec><sec disp-level="2"><title>RNA isolation and purification</title><p>For RNA extraction, the muscle tissue was homogenized mechanically via a steel micropestle (Cat. #6-1062, neoLab, Heidelberg, Germany) in liquid nitrogen. Total RNA was extracted via the <italic>Maxwell 16 LEV simplyRNA Tissue Kit</italic> (Cat. #AS1280, Promega, Madison, WI) on a Maxwell 16 Instrument (Cat. #AS2000, Promega, Madison, WI) according to the manufacturer&#x02019;s instructions. RNA concentration was measured with a NanoDrop 1000 Spectrophotometer (Peqlab, Erlangen, Germany).</p></sec><sec disp-level="2"><title>Microarray</title><p>All reagents and instrumentation pertaining to oligonucleotide microarrays were purchased from Affymetrix (Affymetrix, Santa Clara, CA, USA, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.affymetrix.com">http://www.affymetrix.com</ext-link>). Total RNA (100&#x02009;ng) was used for amplification and <italic>in-vitro</italic> transcription using the Genechip 3&#x02032; IVT Express Kit as per the manufacturer&#x02019;s instructions (Affymetrix). The amplified RNA was purified with magnetic beads and 15&#x02009;&#x003bc;g Biotin-aRNA was fragmented with fragmentation reagent. 12.5&#x02009;&#x003bc;g of fragmented aRNA was hybridized to Affymetrix Mouse Genome 430 2.0 arrays along with hybridization cocktail solution and then placed in Genechip Hybridization Oven-645 (Affymetrix) rotating at 60&#x02009;rpm at 45&#x02009;&#x000b0;C for 16&#x02009;h. After the incubation arrays were washed on a Genechip Fluidics Station-450 (Affymetrix) and stained with Affymetrix HWS kit as per manufacturer&#x02019;s protocols. The chips were scanned with Affymetrix Gene-Chip Scanner-3000-7G and the quality control matrices were confirmed with Affymetrix GCOS software following the manufacturer&#x02019;s guidelines.</p></sec><sec disp-level="2"><title>Statistical analysis and identification of differentially expressed genes</title><p>Robust Multi-array Analysis was used for background correction, summarization and normalization<xref ref-type="bibr" rid="b50">50</xref>. The quantile normalization method was implemented to normalize the raw dataset executable with R-package<xref ref-type="bibr" rid="b51">51</xref>, carried out at the probe feature level. The differentially expressed genes were described by a linear model implementing R and the LIMMA packages<xref ref-type="bibr" rid="b52">52</xref>. Differentially expressed genes were determined based on cut-off values of 5% error rate (P&#x02009;&#x0003c;&#x02009;0.05), calculated by moderated t- statistics according to Benjamini and Hochberg (Multiple Testing Correction)<xref ref-type="bibr" rid="b53">53</xref>. Additionally, to identify significantly expressed genes between the control and <italic>dysp</italic> sample groups, the size of change with the threshold value &#x02265; &#x000b1;1.5 was used. Principal component (PC) analysis was performed using the Stats package in R using the prcomp function. The &#x0201c;x&#x0201d; attribute of the prcomp object was used to generate 2 dimensional scatter plots. Microarray data are available in the ArrayExpress database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/arrayexpress">www.ebi.ac.uk/arrayexpress</ext-link>) under the accession number E-MTAB-3608.</p></sec><sec disp-level="2"><title>Gene Ontology Enrichment Analysis</title><p>Gene Ontology analysis for the list of differentially expressed genes was performed to identify their prevalence in Biological processes and in molecular functions and pathways, with the help of the <italic>DAVID</italic> (Database for Annotation, Visualization and Integrated Discovery, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://david.abcc.ncifcrf.gov/">http://david.abcc.ncifcrf.gov/</ext-link>)<xref ref-type="bibr" rid="b15">15</xref>, MGI<xref ref-type="bibr" rid="b54">54</xref> and Enrichr<xref ref-type="bibr" rid="b16">16</xref> functional annotation tools, with the Fisher Exact P- value set to &#x0003c;0.01.</p></sec><sec disp-level="2"><title>cDNA synthesis and qRT-PCRs</title><p>100&#x02009;ng total RNA of each sample were used for cDNA synthesis via the &#x0201c;First Strand cDNA Synthesis Kit&#x0201d; (Cat. #E6550, New England Biolabs, Ipswich, MA) according to the manufacturer&#x02019;s instructions. qRT-PCR was used for determination of the relative gene expression changes of selected genes of interest. All primers (<xref ref-type="table" rid="t4">Table 4</xref>) were designed using the OligoPerfect&#x02122; Designer (Life Technologies) with a T<sub>m</sub> range of 58&#x02009;&#x000b0;C&#x02013;60&#x02009;&#x000b0;C , an optimal length of 20 bases and an amplicon of 100&#x02013;120&#x02009;bp, and were purchased from Sigma Aldrich. The qRT-PCR reaction mixtures were mixed in 0.1&#x02009;ml MicroAmp Fast 96-well Reaction Plates (Cat. #4346907, life Technologies, Darmstadt, Germany). The GoTaq&#x000ae; qPCR Master Mix kit (Cat. #A6001, Promega, Madison, WI) was used for preparation of the reaction mixtures according to the manufacturer&#x02019;s instructions in a final volume of 20&#x02009;&#x003bc;l per reaction. cDNAs were diluted 1:10 with RNase-free water and 4&#x02009;&#x003bc;l of the dilutions were used as a reaction template. qRT-PCRs were performed in a thermo-cycler (StepOnePlus&#x02122; real-time PCR System, life Technologies, Darmstadt, Germany). Triplicates of each sample were assayed in one run (50 cycles) composed of three stages: 1. Activation at 95&#x02009;&#x000b0;C for 10&#x02009;min, 2. Denaturation at 95&#x02009;&#x000b0;C for 15&#x02009;s and annealing/extension at 60&#x02009;&#x000b0;C for 1&#x02009;min for each cycle, 3. Melt curve at 95&#x02009;&#x000b0;C for 15&#x02009;s, 60&#x02009;&#x000b0;C for 1&#x02009;min and 95&#x02009;&#x000b0;C for 15&#x02009;s.</p><p>qRT-PCR data were analyzed using relative quantification and the Ct method as described previously<xref ref-type="bibr" rid="b55">55</xref>, with the <italic>Gapdh</italic> gene as the endogenous control. The level of gene expression was calculated as &#x00394;CT by subtracting the averaged Ct values (Ct refers to the threshold cycle) for <italic>Gapdh</italic> from those for the gene of interest. The difference in expression (<italic>dysp</italic> vs. control) was calculated as &#x00394;&#x00394;Ct. The relative expression of genes of interest was calculated and expressed as FC, 2<sup>&#x02212;&#x00394;&#x00394;Ct</sup>. Bars in <xref ref-type="fig" rid="f3">Figs 3</xref> and <xref ref-type="fig" rid="f4">4</xref> are represented as FCs plus/minus the standard error of the mean (S.E.M.) relative to the control group, which was normalized to an expression rate of 1. For each gene the expression levels of the <italic>dysp</italic> and control samples were subjected to an unpaired t-test and expression rates were assumed to be statistically significant upon a P value&#x02009;&#x02264;&#x02009;0.05.</p></sec></sec><sec disp-level="1"><title>Additional Information</title><p><bold>How to cite this article</bold>: Filipova, D. <italic>et al.</italic> Gene profiling of embryonic skeletal muscle lacking type I ryanodine receptor Ca<sup>2+</sup> release channel. <italic>Sci. Rep.</italic>
<bold>6</bold>, 20050; doi: 10.1038/srep20050 (2016).</p></sec><sec sec-type="supplementary-material" id="S1"><title>Supplementary Material</title><supplementary-material id="d33e23" content-type="local-data"><caption><title>Supplementary Information</title></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep20050-s1.pdf"/></supplementary-material></sec></body><back><ack><p>We thank Mrs. Tamara Rotshteyn and Mrs. Margit Henry for their excellent technical assistance in the microarray experiments, Mrs. Mariana Carstov for her superb help with the histology, Dr. Paul Allen (UC Davis) for sharing the dyspedic mouse model and Dr. Lubomir Lubomirov for the valuable discussions.</p></ack><ref-list><ref id="b1"><mixed-citation publication-type="journal"><name><surname>Berchtold</surname><given-names>M. W.</given-names></name>, <name><surname>Brinkmeier</surname><given-names>H.</given-names></name> &#x00026; <name><surname>Muntener</surname><given-names>M.</given-names></name>
<article-title>Calcium ion in skeletal muscle: its crucial role for muscle function, plasticity, and disease</article-title>. <source>Physiol Rev</source>
<volume>80</volume>, <fpage>1215</fpage>&#x02013;<lpage>65</lpage> (<year>2000</year>).<pub-id pub-id-type="pmid">10893434</pub-id></mixed-citation></ref><ref id="b2"><mixed-citation publication-type="journal"><name><surname>Gehlert</surname><given-names>S.</given-names></name>, <name><surname>Bloch</surname><given-names>W.</given-names></name> &#x00026; <name><surname>Suhr</surname><given-names>F.</given-names></name>
<article-title>Ca2+-Dependent Regulations and Signaling in Skeletal Muscle: From Electro-Mechanical Coupling to Adaptation</article-title>. <source>Int J Mol Sci</source>
<volume>16</volume>, <fpage>1066</fpage>&#x02013;<lpage>1095</lpage> (<year>2015</year>).<pub-id pub-id-type="pmid">25569087</pub-id></mixed-citation></ref><ref id="b3"><mixed-citation publication-type="journal"><name><surname>Szent-Gyorgyi</surname><given-names>A. G.</given-names></name>
<article-title>Calcium regulation of muscle contraction</article-title>. <source>Biophys J</source>
<volume>15</volume>, <fpage>707</fpage>&#x02013;<lpage>23</lpage> (<year>1975</year>).<pub-id pub-id-type="pmid">806311</pub-id></mixed-citation></ref><ref id="b4"><mixed-citation publication-type="journal"><name><surname>Jaimovich</surname><given-names>E.</given-names></name> &#x00026; <name><surname>Rojas</surname><given-names>E.</given-names></name>
<article-title>Intracellular Ca2+ transients induced by high external K+ and tetracaine in cultured rat myotubes</article-title>. <source>Cell Calcium</source>
<volume>15</volume>, <fpage>356</fpage>&#x02013;<lpage>68</lpage> (<year>1994</year>).<pub-id pub-id-type="pmid">8033194</pub-id></mixed-citation></ref><ref id="b5"><mixed-citation publication-type="journal"><name><surname>Estrada</surname><given-names>M.</given-names></name>
<italic>et al.</italic>
<article-title>Calcium transients in 1B5 myotubes lacking ryanodine receptors are related to inositol trisphosphate receptors</article-title>. <source>J Biol Chem</source>
<volume>276</volume>, <fpage>22868</fpage>&#x02013;<lpage>74</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11301324</pub-id></mixed-citation></ref><ref id="b6"><mixed-citation publication-type="journal"><name><surname>Jaimovich</surname><given-names>E.</given-names></name>, <name><surname>Reyes</surname><given-names>R.</given-names></name>, <name><surname>Liberona</surname><given-names>J. L.</given-names></name> &#x00026; <name><surname>Powell</surname><given-names>J. A.</given-names></name>
<article-title>IP(3) receptors, IP(3) transients, and nucleus-associated Ca(2+) signals in cultured skeletal muscle</article-title>. <source>Am J Physiol Cell Physiol</source>
<volume>278</volume>, <fpage>C998</fpage>&#x02013;<lpage>C1010</lpage> (<year>2000</year>).<pub-id pub-id-type="pmid">10794674</pub-id></mixed-citation></ref><ref id="b7"><mixed-citation publication-type="journal"><name><surname>Powell</surname><given-names>J. A.</given-names></name>
<italic>et al.</italic>
<article-title>IP(3) receptor function and localization in myotubes: an unexplored Ca(2+) signaling pathway in skeletal muscle</article-title>. <source>J Cell Sci</source>
<volume>114</volume>, <fpage>3673</fpage>&#x02013;<lpage>83</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11707519</pub-id></mixed-citation></ref><ref id="b8"><mixed-citation publication-type="journal"><name><surname>Carrasco</surname><given-names>M. A.</given-names></name>
<italic>et al.</italic>
<article-title>Depolarization-induced slow calcium transients activate early genes in skeletal muscle cells</article-title>. <source>Am J Physiol Cell Physiol</source>
<volume>284</volume>, <fpage>C1438</fpage>&#x02013;<lpage>47</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12529240</pub-id></mixed-citation></ref><ref id="b9"><mixed-citation publication-type="journal"><name><surname>Espinosa</surname><given-names>A.</given-names></name>
<italic>et al.</italic>
<article-title>Myotube depolarization generates reactive oxygen species through NAD(P)H oxidase; ROS-elicited Ca2+ stimulates ERK, CREB, early genes</article-title>. <source>J Cell Physiol</source>
<volume>209</volume>, <fpage>379</fpage>&#x02013;<lpage>88</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16897752</pub-id></mixed-citation></ref><ref id="b10"><mixed-citation publication-type="journal"><name><surname>Contreras-Ferrat</surname><given-names>A.</given-names></name>, <name><surname>Lavandero</surname><given-names>S.</given-names></name>, <name><surname>Jaimovich</surname><given-names>E.</given-names></name> &#x00026; <name><surname>Klip</surname><given-names>A.</given-names></name>
<article-title>Calcium signaling in insulin action on striated muscle</article-title>. <source>Cell Calcium</source>
<volume>56</volume>, <fpage>390</fpage>&#x02013;<lpage>6</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">25224502</pub-id></mixed-citation></ref><ref id="b11"><mixed-citation publication-type="journal"><name><surname>Blaauw</surname><given-names>B.</given-names></name>
<italic>et al.</italic>
<article-title>No evidence for inositol 1,4,5-trisphosphate-dependent Ca<sup>2+</sup> release in isolated fibers of adult mouse skeletal muscle.</article-title>. <source>J Gen Physiol</source>
<volume>140</volume>, <fpage>235</fpage>&#x02013;<lpage>41</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22802359</pub-id></mixed-citation></ref><ref id="b12"><mixed-citation publication-type="journal"><name><surname>Takeshima</surname><given-names>H.</given-names></name>
<italic>et al.</italic>
<article-title>Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene</article-title>. <source>Nature</source>
<volume>369</volume>, <fpage>556</fpage>&#x02013;<lpage>9</lpage> (<year>1994</year>).<pub-id pub-id-type="pmid">7515481</pub-id></mixed-citation></ref><ref id="b13"><mixed-citation publication-type="journal"><name><surname>Polster</surname><given-names>A.</given-names></name>, <name><surname>Ohrtman</surname><given-names>J. D.</given-names></name>, <name><surname>Beam</surname><given-names>K. G.</given-names></name> &#x00026; <name><surname>Papadopoulos</surname><given-names>S.</given-names></name>
<article-title>Fluorescence resonance energy transfer (FRET) indicates that association with the type I ryanodine receptor (RyR1) causes reorientation of multiple cytoplasmic domains of the dihydropyridine receptor (DHPR) alpha(1S) subunit</article-title>. <source>J Biol Chem</source>
<volume>287</volume>, <fpage>41560</fpage>&#x02013;<lpage>8</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">23071115</pub-id></mixed-citation></ref><ref id="b14"><mixed-citation publication-type="journal"><name><surname>Zvaritch</surname><given-names>E.</given-names></name>
<italic>et al.</italic>
<article-title>An Ryr1I4895T mutation abolishes Ca2+ release channel function and delays development in homozygous offspring of a mutant mouse line</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>104</volume>, <fpage>18537</fpage>&#x02013;<lpage>42</lpage> (<year>2007</year>).<pub-id pub-id-type="pmid">18003898</pub-id></mixed-citation></ref><ref id="b15"><mixed-citation publication-type="journal"><name><surname>Huang da</surname><given-names>W.</given-names></name>, <name><surname>Sherman</surname><given-names>B. T.</given-names></name> &#x00026; <name><surname>Lempicki</surname><given-names>R. A.</given-names></name>
<article-title>Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources</article-title>. <source>Nat Protoc</source>
<volume>4</volume>, <fpage>44</fpage>&#x02013;<lpage>57</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19131956</pub-id></mixed-citation></ref><ref id="b16"><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>E. Y.</given-names></name>
<italic>et al.</italic>
<article-title>Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool</article-title>. <source>BMC Bioinformatics</source>
<volume>14</volume>, <fpage>128</fpage> (<year>2013</year>).<pub-id pub-id-type="pmid">23586463</pub-id></mixed-citation></ref><ref id="b17"><mixed-citation publication-type="journal"><name><surname>Runchel</surname><given-names>C.</given-names></name>, <name><surname>Matsuzawa</surname><given-names>A.</given-names></name> &#x00026; <name><surname>Ichijo</surname><given-names>H.</given-names></name>
<article-title>Mitogen-activated protein kinases in mammalian oxidative stress responses</article-title>. <source>Antioxid Redox Signal</source>
<volume>15</volume>, <fpage>205</fpage>&#x02013;<lpage>18</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21050144</pub-id></mixed-citation></ref><ref id="b18"><mixed-citation publication-type="journal"><name><surname>Wada</surname><given-names>T.</given-names></name> &#x00026; <name><surname>Penninger</surname><given-names>J. M.</given-names></name>
<article-title>Mitogen-activated protein kinases in apoptosis regulation</article-title>. <source>Oncogene</source>
<volume>23</volume>, <fpage>2838</fpage>&#x02013;<lpage>49</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15077147</pub-id></mixed-citation></ref><ref id="b19"><mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>G. S.</given-names></name>
<article-title>The functional interactions between the p53 and MAPK signaling pathways</article-title>. <source>Cancer Biol Ther</source>
<volume>3</volume>, <fpage>156</fpage>&#x02013;<lpage>61</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">14764989</pub-id></mixed-citation></ref><ref id="b20"><mixed-citation publication-type="journal"><name><surname>Sumiyoshi</surname><given-names>H.</given-names></name>, <name><surname>Laub</surname><given-names>F.</given-names></name>, <name><surname>Yoshioka</surname><given-names>H.</given-names></name> &#x00026; <name><surname>Ramirez</surname><given-names>F.</given-names></name>
<article-title>Embryonic expression of type XIX collagen is transient and confined to muscle cells</article-title>. <source>Dev Dyn</source>
<volume>220</volume>, <fpage>155</fpage>&#x02013;<lpage>62</lpage> (<year>2001</year>).<pub-id pub-id-type="pmid">11169848</pub-id></mixed-citation></ref><ref id="b21"><mixed-citation publication-type="journal"><name><surname>Bentzinger</surname><given-names>C. F.</given-names></name>, <name><surname>Wang</surname><given-names>Y. X.</given-names></name> &#x00026; <name><surname>Rudnicki</surname><given-names>M. A.</given-names></name>
<article-title>Building muscle: molecular regulation of myogenesis</article-title>. <source>Cold Spring Harb Perspect Biol</source>
<volume>4</volume>, doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a008342</pub-id> (<year>2012</year>).</mixed-citation></ref><ref id="b22"><mixed-citation publication-type="journal"><name><surname>Robinson</surname><given-names>R.</given-names></name>, <name><surname>Carpenter</surname><given-names>D.</given-names></name>, <name><surname>Shaw</surname><given-names>M. A.</given-names></name>, <name><surname>Halsall</surname><given-names>J.</given-names></name> &#x00026; <name><surname>Hopkins</surname><given-names>P.</given-names></name>
<article-title>Mutations in RYR1 in malignant hyperthermia and central core disease</article-title>. <source>Hum Mutat</source>
<volume>27</volume>, <fpage>977</fpage>&#x02013;<lpage>89</lpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16917943</pub-id></mixed-citation></ref><ref id="b23"><mixed-citation publication-type="journal"><name><surname>Gonzalez de Aguilar</surname><given-names>J. L.</given-names></name>
<italic>et al.</italic>
<article-title>Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model</article-title>. <source>Physiol Genomics</source>
<volume>32</volume>, <fpage>207</fpage>&#x02013;<lpage>18</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">18000159</pub-id></mixed-citation></ref><ref id="b24"><mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>X. X.</given-names></name>
<italic>et al.</italic>
<article-title>Runx1 prevents wasting, myofibrillar disorganization, and autophagy of skeletal muscle</article-title>. <source>Genes &#x00026; Development</source>
<volume>19</volume>, <fpage>1715</fpage>&#x02013;<lpage>1722</lpage> (<year>2005</year>).<pub-id pub-id-type="pmid">16024660</pub-id></mixed-citation></ref><ref id="b25"><mixed-citation publication-type="journal"><name><surname>Witzemann</surname><given-names>V.</given-names></name>, <name><surname>Brenner</surname><given-names>H. R.</given-names></name> &#x00026; <name><surname>Sakmann</surname><given-names>B.</given-names></name>
<article-title>Neural Factors Regulate Achr Subunit Messenger-Rnas at Rat Neuromuscular Synapses</article-title>. <source>Journal of Cell Biology</source>
<volume>114</volume>, <fpage>125</fpage>&#x02013;<lpage>141</lpage> (<year>1991</year>).<pub-id pub-id-type="pmid">1646821</pub-id></mixed-citation></ref><ref id="b26"><mixed-citation publication-type="journal"><name><surname>Ohno</surname><given-names>K.</given-names></name>, <name><surname>Sadeh</surname><given-names>M.</given-names></name>, <name><surname>Blatt</surname><given-names>I.</given-names></name>, <name><surname>Brengman</surname><given-names>J. M.</given-names></name> &#x00026; <name><surname>Engel</surname><given-names>A. G.</given-names></name>
<article-title>E-box mutations in the RAPSN promoter region in eight cases with congenital myasthenic syndrome</article-title>. <source>Hum Mol Genet</source>
<volume>12</volume>, <fpage>739</fpage>&#x02013;<lpage>48</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12651869</pub-id></mixed-citation></ref><ref id="b27"><mixed-citation publication-type="journal"><name><surname>Irintchev</surname><given-names>A.</given-names></name>, <name><surname>Salvini</surname><given-names>T. F.</given-names></name>, <name><surname>Faissner</surname><given-names>A.</given-names></name> &#x00026; <name><surname>Wernig</surname><given-names>A.</given-names></name>
<article-title>Differential expression of tenascin after denervation, damage or paralysis of mouse soleus muscle</article-title>. <source>J Neurocytol</source>
<volume>22</volume>, <fpage>955</fpage>&#x02013;<lpage>65</lpage> (<year>1993</year>).<pub-id pub-id-type="pmid">7507977</pub-id></mixed-citation></ref><ref id="b28"><mixed-citation publication-type="journal"><name><surname>Llano-Diez</surname><given-names>M.</given-names></name>, <name><surname>Gustafson</surname><given-names>A. M.</given-names></name>, <name><surname>Olsson</surname><given-names>C.</given-names></name>, <name><surname>Goransson</surname><given-names>H.</given-names></name> &#x00026; <name><surname>Larsson</surname><given-names>L.</given-names></name>
<article-title>Muscle wasting and the temporal gene expression pattern in a novel rat intensive care unit model</article-title>. <source>BMC Genomics</source>
<volume>12</volume>, <fpage>602</fpage> (<year>2011</year>).<pub-id pub-id-type="pmid">22165895</pub-id></mixed-citation></ref><ref id="b29"><mixed-citation publication-type="journal"><name><surname>Shtilbans</surname><given-names>A.</given-names></name>
<italic>et al.</italic>
<article-title>Differential gene expression in patients with amyotrophic lateral sclerosis</article-title>. <source>Amyotroph Lateral Scler</source>
<volume>12</volume>, <fpage>250</fpage>&#x02013;<lpage>6</lpage> (<year>2011</year>).<pub-id pub-id-type="pmid">21375368</pub-id></mixed-citation></ref><ref id="b30"><mixed-citation publication-type="journal"><name><surname>Miller</surname><given-names>M. K.</given-names></name>
<italic>et al.</italic>
<article-title>The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp and DARP as a family of titin filament-based stress response molecules</article-title>. <source>J Mol Biol</source>
<volume>333</volume>, <fpage>951</fpage>&#x02013;<lpage>64</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">14583192</pub-id></mixed-citation></ref><ref id="b31"><mixed-citation publication-type="journal"><name><surname>Nakada</surname><given-names>C.</given-names></name>
<italic>et al.</italic>
<article-title>Cardiac ankyrin repeat protein is preferentially induced in atrophic myofibers of congenital myopathy and spinal muscular atrophy</article-title>. <source>Pathol Int</source>
<volume>53</volume>, <fpage>653</fpage>&#x02013;<lpage>8</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">14516314</pub-id></mixed-citation></ref><ref id="b32"><mixed-citation publication-type="journal"><name><surname>Mittal</surname><given-names>A.</given-names></name>
<italic>et al.</italic>
<article-title>The TWEAK-Fn14 system is a critical regulator of denervation-induced skeletal muscle atrophy in mice</article-title>. <source>Journal of Cell Biology</source>
<volume>188</volume>, <fpage>833</fpage>&#x02013;<lpage>849</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20308426</pub-id></mixed-citation></ref><ref id="b33"><mixed-citation publication-type="journal"><name><surname>Pogozelski</surname><given-names>A. R.</given-names></name>
<italic>et al.</italic>
<article-title>p38gamma mitogen-activated protein kinase is a key regulator in skeletal muscle metabolic adaptation in mice</article-title>. <source>PLoS One</source>
<volume>4</volume>, <fpage>e7934</fpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19936205</pub-id></mixed-citation></ref><ref id="b34"><mixed-citation publication-type="journal"><name><surname>Eltit</surname><given-names>J. M.</given-names></name>
<italic>et al.</italic>
<article-title>RyR1-mediated Ca2+ leak and Ca2+ entry determine resting intracellular Ca2+ in skeletal myotubes</article-title>. <source>J Biol Chem</source>
<volume>285</volume>, <fpage>13781</fpage>&#x02013;<lpage>7</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">20207743</pub-id></mixed-citation></ref><ref id="b35"><mixed-citation publication-type="journal"><name><surname>Enslen</surname><given-names>H.</given-names></name>, <name><surname>Tokumitsu</surname><given-names>H.</given-names></name>, <name><surname>Stork</surname><given-names>P. J.</given-names></name>, <name><surname>Davis</surname><given-names>R. J.</given-names></name> &#x00026; <name><surname>Soderling</surname><given-names>T. R.</given-names></name>
<article-title>Regulation of mitogen-activated protein kinases by a calcium/calmodulin-dependent protein kinase cascade</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>93</volume>, <fpage>10803</fpage>&#x02013;<lpage>8</lpage> (<year>1996</year>).<pub-id pub-id-type="pmid">8855261</pub-id></mixed-citation></ref><ref id="b36"><mixed-citation publication-type="journal"><name><surname>Chuderland</surname><given-names>D.</given-names></name> &#x00026; <name><surname>Seger</surname><given-names>R.</given-names></name>
<article-title>Calcium regulates ERK signaling by modulating its protein-protein interactions</article-title>. <source>Commun Integr Biol</source>
<volume>1</volume>, <fpage>4</fpage>&#x02013;<lpage>5</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">19704446</pub-id></mixed-citation></ref><ref id="b37"><mixed-citation publication-type="journal"><name><surname>Benavides Damm</surname><given-names>T.</given-names></name> &#x00026; <name><surname>Egli</surname><given-names>M.</given-names></name>
<article-title>Calcium&#x02019;s role in mechanotransduction during muscle development</article-title>. <source>Cell Physiol Biochem</source>
<volume>33</volume>, <fpage>249</fpage>&#x02013;<lpage>72</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24525559</pub-id></mixed-citation></ref><ref id="b38"><mixed-citation publication-type="journal"><name><surname>Frolova</surname><given-names>E. G.</given-names></name>
<italic>et al.</italic>
<article-title>Control of organization and function of muscle and tendon by thrombospondin-4</article-title>. <source>Matrix Biol</source>
<volume>37</volume>, <fpage>35</fpage>&#x02013;<lpage>48</lpage> (<year>2014</year>).<pub-id pub-id-type="pmid">24589453</pub-id></mixed-citation></ref><ref id="b39"><mixed-citation publication-type="journal"><name><surname>von Maltzahn</surname><given-names>J.</given-names></name>, <name><surname>Chang</surname><given-names>N. C.</given-names></name>, <name><surname>Bentzinger</surname><given-names>C. F.</given-names></name> &#x00026; <name><surname>Rudnicki</surname><given-names>M. A.</given-names></name>
<article-title>Wnt signaling in myogenesis</article-title>. <source>Trends Cell Biol</source>
<volume>22</volume>, <fpage>602</fpage>&#x02013;<lpage>9</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22944199</pub-id></mixed-citation></ref><ref id="b40"><mixed-citation publication-type="journal"><name><surname>Ekici</surname><given-names>A. B.</given-names></name>
<italic>et al.</italic>
<article-title>Disturbed Wnt Signalling due to a Mutation in CCDC88C Causes an Autosomal Recessive Non-Syndromic Hydrocephalus with Medial Diverticulum</article-title>. <source>Mol Syndromol</source>
<volume>1</volume>, <fpage>99</fpage>&#x02013;<lpage>112</lpage> (<year>2010</year>).<pub-id pub-id-type="pmid">21031079</pub-id></mixed-citation></ref><ref id="b41"><mixed-citation publication-type="journal"><name><surname>von Maltzahn</surname><given-names>J.</given-names></name>, <name><surname>Bentzinger</surname><given-names>C. F.</given-names></name> &#x00026; <name><surname>Rudnicki</surname><given-names>M. A.</given-names></name>
<article-title>Wnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle</article-title>. <source>Nat Cell Biol</source>
<volume>14</volume>, <fpage>186</fpage>&#x02013;<lpage>91</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">22179044</pub-id></mixed-citation></ref><ref id="b42"><mixed-citation publication-type="journal"><name><surname>Buck</surname><given-names>E. D.</given-names></name>, <name><surname>Nguyen</surname><given-names>H. T.</given-names></name>, <name><surname>Pessah</surname><given-names>I. N.</given-names></name> &#x00026; <name><surname>Allen</surname><given-names>P. D.</given-names></name>
<article-title>Dyspedic mouse skeletal muscle expresses major elements of the triadic junction but lacks detectable ryanodine receptor protein and function</article-title>. <source>J Biol Chem</source>
<volume>272</volume>, <fpage>7360</fpage>&#x02013;<lpage>7</lpage> (<year>1997</year>).<pub-id pub-id-type="pmid">9054435</pub-id></mixed-citation></ref><ref id="b43"><mixed-citation publication-type="journal"><name><surname>Knoll</surname><given-names>R.</given-names></name>, <name><surname>Buyandelger</surname><given-names>B.</given-names></name> &#x00026; <name><surname>Lab</surname><given-names>M.</given-names></name>
<article-title>The sarcomeric Z-disc and Z-discopathies</article-title>. <source>J Biomed Biotechnol</source>
<volume>2011</volume>, <fpage>569628</fpage> (<year>2011</year>).<pub-id pub-id-type="pmid">22028589</pub-id></mixed-citation></ref><ref id="b44"><mixed-citation publication-type="journal"><name><surname>Bayle</surname><given-names>J.</given-names></name>
<italic>et al.</italic>
<article-title>Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis</article-title>. <source>J Invest Dermatol</source>
<volume>128</volume>, <fpage>871</fpage>&#x02013;<lpage>81</lpage> (<year>2008</year>).<pub-id pub-id-type="pmid">17943183</pub-id></mixed-citation></ref><ref id="b45"><mixed-citation publication-type="journal"><name><surname>Zweers</surname><given-names>M. C.</given-names></name>
<italic>et al.</italic>
<article-title>Deficiency of tenascin-X causes abnormalities in dermal elastic fiber morphology</article-title>. <source>J Invest Dermatol</source>
<volume>122</volume>, <fpage>885</fpage>&#x02013;<lpage>91</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15102077</pub-id></mixed-citation></ref><ref id="b46"><mixed-citation publication-type="journal"><name><surname>Sabatier</surname><given-names>L.</given-names></name>
<italic>et al.</italic>
<article-title>Fibrillin assembly requires fibronectin</article-title>. <source>Mol Biol Cell</source>
<volume>20</volume>, <fpage>846</fpage>&#x02013;<lpage>58</lpage> (<year>2009</year>).<pub-id pub-id-type="pmid">19037100</pub-id></mixed-citation></ref><ref id="b47"><mixed-citation publication-type="journal"><name><surname>Gabriel</surname><given-names>L. A.</given-names></name>
<italic>et al.</italic>
<article-title>ADAMTSL4, a secreted glycoprotein widely distributed in the eye, binds fibrillin-1 microfibrils and accelerates microfibril biogenesis</article-title>. <source>Invest Ophthalmol Vis Sci</source>
<volume>53</volume>, <fpage>461</fpage>&#x02013;<lpage>9</lpage> (<year>2012</year>).<pub-id pub-id-type="pmid">21989719</pub-id></mixed-citation></ref><ref id="b48"><mixed-citation publication-type="journal"><name><surname>Kjaer</surname><given-names>M.</given-names></name>
<article-title>Role of extracellular matrix in adaptation of tendon and skeletal muscle to mechanical loading</article-title>. <source>Physiol Rev</source>
<volume>84</volume>, <fpage>649</fpage>&#x02013;<lpage>98</lpage> (<year>2004</year>).<pub-id pub-id-type="pmid">15044685</pub-id></mixed-citation></ref><ref id="b49"><mixed-citation publication-type="journal"><name><surname>Beam</surname><given-names>K. G.</given-names></name> &#x00026; <name><surname>Franzini-Armstrong</surname><given-names>C.</given-names></name>
<article-title>Functional and structural approaches to the study of excitation-contraction coupling</article-title>. <source>Methods Cell Biol</source>
<volume>52</volume>, <fpage>283</fpage>&#x02013;<lpage>306</lpage> (<year>1997</year>).<pub-id pub-id-type="pmid">9379955</pub-id></mixed-citation></ref><ref id="b50"><mixed-citation publication-type="journal"><name><surname>Bolstad</surname><given-names>B. M.</given-names></name>, <name><surname>Irizarry</surname><given-names>R. A.</given-names></name>, <name><surname>Astrand</surname><given-names>M.</given-names></name> &#x00026; <name><surname>Speed</surname><given-names>T. P.</given-names></name>
<article-title>A comparison of normalization methods for high density oligonucleotide array data based on variance and bias</article-title>. <source>Bioinformatics</source>
<volume>19</volume>, <fpage>185</fpage>&#x02013;<lpage>93</lpage> (<year>2003</year>).<pub-id pub-id-type="pmid">12538238</pub-id></mixed-citation></ref><ref id="b51"><mixed-citation publication-type="journal"><name><surname>Irizarry</surname><given-names>R. A.</given-names></name>, <name><surname>Gautier</surname><given-names>L.</given-names></name> &#x00026; <name><surname>Cope</surname><given-names>L. M.</given-names></name>
<article-title>An R Package for Analyses of Affymetrix Oligonucleotide Arrays</article-title>, in <source>The Analysis of Gene Expression Data: Methods and Software</source>. (eds. <name><surname>Parmigiani</surname><given-names>G.</given-names></name><italic>et al.</italic>) <volume>Ch. 4</volume>, <fpage>102</fpage>&#x02013;<lpage>119</lpage> (Springer, <year>2003</year>).</mixed-citation></ref><ref id="b52"><mixed-citation publication-type="journal"><name><surname>Smyth</surname><given-names>G. K.</given-names></name>
<article-title>Linear models and empirical bayes methods for assessing differential expression in microarray experiments</article-title>. <source>Stat Appl Genet Mol Biol</source>
<volume>3</volume>, Article3, doi: <pub-id pub-id-type="doi">10.2202/1544-6115.1027</pub-id> (<year>2004</year>).</mixed-citation></ref><ref id="b53"><mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y.</given-names></name> &#x00026; <name><surname>Hochberg</surname><given-names>Y.</given-names></name>
<article-title>Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing</article-title>. <source>Journal of the Royal Statistical Society. Series B (Methodological)</source>
<volume>57</volume>, <fpage>289</fpage>&#x02013;<lpage>300</lpage> (<year>1995</year>).</mixed-citation></ref><ref id="b54"><mixed-citation publication-type="journal"><name><surname>Smith</surname><given-names>C. M.</given-names></name>
<italic>et al.</italic>
<article-title>The mouse Gene Expression Database (GXD): 2014 update</article-title>. <source>Nucleic Acids Res</source>
<volume>42</volume><source>, D818-24</source> (<year>2014</year>).</mixed-citation></ref><ref id="b55"><mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>J. S.</given-names></name>, <name><surname>Reed</surname><given-names>A.</given-names></name>, <name><surname>Chen</surname><given-names>F.</given-names></name> &#x00026; <name><surname>Stewart</surname><given-names>C. N.</given-names><suffix>, Jr.</suffix></name>
<article-title>Statistical analysis of real-time PCR data</article-title>. <source>BMC Bioinformatics</source>
<volume>7</volume>, <fpage>85</fpage> (<year>2006</year>).<pub-id pub-id-type="pmid">16504059</pub-id></mixed-citation></ref></ref-list><fn-group><fn><p><bold>Author Contributions</bold> D.F., A.W. and S.P. designed research, performed research, analysed data and wrote the paper. M.A., N.F.L., A.B. and J.A.G. performed experiments and analysed data. M.D., G.P., J.H. and A.S. analysed data and wrote the paper. All authors reviewed the manuscript.</p></fn></fn-group></back><floats-group><fig id="f1"><label>Figure 1</label><caption><title>Developmental retardation and disorganization of skeletal muscle of <italic>dysp</italic> mice.</title><p>(<bold>a</bold>) Heterozygous controls (het, left) and <italic>dysp</italic> (right) littermates at day E18.5 from three different litters (I, II and III). The <italic>dysp</italic> littermates display abnormal spine curvature, small limbs and enlarged necks. (<bold>b</bold>) At E18.5, the distal hind limb of control littermates contains well-developed muscle fibres (*) organized in fascicles, which are surrounded by an epimysial fascia (arrows). (<bold>c</bold>) In contrast, at E18.5 the distal hind limb of <italic>dysp</italic> mice contains only immature small fibers (arrows) in a scattered distribution, lacking a fascia (<bold>b</bold>,<bold>c</bold>): H&#x00026;E staining; original magnification &#x000d7; 50 (<bold>a</bold>,<bold>b</bold>); &#x000d7; 200 (insets I); &#x000d7; 400 (insets II).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep20050-f1"/></fig><fig id="f2"><label>Figure 2</label><caption><title>Functional classification of the 318 unique DEGs.</title><p>(<bold>a</bold>) Downregulated (FC&#x02009;&#x02264;&#x02009;&#x02212;1.5, P&#x02009;&#x0003c;&#x02009;0.05) and (<bold>b</bold>) upregulated (FC&#x02009;&#x02265;&#x02009;1.5, P&#x02009;&#x0003c;&#x02009;0.05) genes were classified according to their involvement in biological processes, cellular components and molecular functions via <italic>DAVID GO</italic><xref ref-type="bibr" rid="b15">15</xref> and the 10 most significantly (P-value&#x02009;&#x02264;&#x02009;0.05, <xref ref-type="supplementary-material" rid="S1">Supplementary Table S2</xref>) regulated GO categories are represented as percentage of all genes from these categories. Genes not matching any of the classes are not considered in the above pie charts. All DEGs were subjected to an enrichment analysis via the online gene list analysis tool, <italic>Enrichr</italic><xref ref-type="bibr" rid="b16">16</xref>, and were assigned to different pathways according to the KEGG (<bold>c</bold>), Reactome (<bold>d</bold>) and Panther (<bold>e</bold>) data bases. Bars in (<bold>c</bold>&#x02013;<bold>e</bold>) are in the order of their P-value ranking.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep20050-f2"/></fig><fig id="f3"><label>Figure 3</label><caption><title>Microarray examination and validation via qRT-PCR</title><p>(<bold>a</bold>) Principal component analysis (PCA) for all transcripts identified in the microarrays (left) and for the DEGs having a FC &#x02265; &#x000b1;1.5 and a P value&#x02009;&#x02264;&#x02009;0.05 (right). Each spot subsumes the DEGs of one biological replicate (four control animals, blue, four <italic>dysp</italic> samples, orange). (<bold>b</bold>) Heat map representing the log<sub>2</sub> expression values for the DEGs having a FC &#x02265; &#x000b1;1.5 and P value&#x02009;&#x02264;&#x02009;0.05. Each column represents one biological replicate (columns 1 to 4 represent the <italic>dysp</italic> replicates and columns 5 to 8 represent the control group). (<bold>c, d</bold>) We selected 7 DEGs from the microarrays for re-examination via qRT-PCR: 4 downregulated genes with FCs &#x02212;1.50 (<italic>Trib1</italic>), &#x02212;2.07 (<italic>c-Jun</italic>), &#x02212;2.43 (<italic>c-Fos</italic>) and &#x02212;10.85 (<italic>Myl2</italic>) (<bold>c</bold>), as well as 3 upregulated genes with FCs 1.50 (<italic>Flcn</italic>), 2.02 (<italic>Bai3</italic>) and 5.13 (<italic>Col19a1</italic>) (<bold>d</bold>). <italic>Gapdh</italic> was used as an intrinsic reference. The mRNA levels are expressed as the mean FC of the 4 biological replicates of each group (<italic>dysp</italic> and control), normalized to the FC of the respective control, &#x000b1;S.E.M.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep20050-f3"/></fig><fig id="f4"><label>Figure 4</label><caption><title>Comparison of mRNA levels of key myogenic regulatory factors between control and <italic>dysp</italic> skeletal muscle.</title><p>Displayed are mRNA levels of the regulatory factors <italic>Six1, Six4. Pax3, Pax7, Myf5, MyoD, MyoG</italic> and <italic>Mrf4</italic>, as determined by microarray analyses and via qRT-PCR. Four biological replicates (4x control, 4x <italic>dysp;</italic> 8 animals in total) were run for every gene. In the qRT-PCR analyses, the respective <italic>Gapdh</italic> mRNA levels served as endogenous reference. The values on the ordinate emanate from normalizing the FCs of the 4 biological replicates (control or <italic>dysp</italic>) to the mean of the respective control. Thus, all controls amount to a &#x0201c;Fold change&#x0201d; of 1. Unpaired t-tests were performed for control vs. <italic>dysp</italic> for each gene, *represents a P value&#x02009;&#x02264;&#x02009;0.05, **represents a P value&#x02009;&#x02264;&#x02009;0.01 and ***represents a P value&#x02009;&#x02264;&#x02009;0.001. Error bars are S.E.M.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="srep20050-f4"/></fig><table-wrap position="float" id="t1"><label>Table 1</label><caption><title>The 10 strongest upregulated and downregulated probe sets identified in the microarray analysis.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Probe Set ID</th><th align="center" valign="top" charoff="50">Gene Title</th><th align="center" valign="top" charoff="50">Gene Symbol</th><th align="center" valign="top" charoff="50">FC</th></tr></thead><tbody valign="top"><tr><td colspan="4" align="center" valign="top" charoff="50">Downregulated genes</td></tr><tr><td align="left" valign="top" charoff="50">1448394_at</td><td align="left" valign="top" charoff="50">myosin, light polypeptide 2, regulatory, cardiac, slow</td><td align="center" valign="top" charoff="50">Myl2</td><td align="center" valign="top" charoff="50">&#x02212;10.85</td></tr><tr><td align="left" valign="top" charoff="50">1419145_at</td><td align="left" valign="top" charoff="50">smoothelin-like 1</td><td align="center" valign="top" charoff="50">Smtnl1</td><td align="center" valign="top" charoff="50">&#x02212;9.68</td></tr><tr><td align="left" valign="top" charoff="50">1416713_at</td><td align="left" valign="top" charoff="50">tubulin polymerization-promoting protein family member 3</td><td align="center" valign="top" charoff="50">Tppp3</td><td align="center" valign="top" charoff="50">&#x02212;4.56</td></tr><tr><td align="left" valign="top" charoff="50">1452766_at</td><td align="left" valign="top" charoff="50">tubulin polymerization promoting protein</td><td align="center" valign="top" charoff="50">Tppp</td><td align="center" valign="top" charoff="50">&#x02212;3.91</td></tr><tr><td align="left" valign="top" charoff="50">1418395_at</td><td align="left" valign="top" charoff="50">solute carrier family 47, member 1</td><td align="center" valign="top" charoff="50">Slc47a1</td><td align="center" valign="top" charoff="50">&#x02212;3.66</td></tr><tr><td align="left" valign="top" charoff="50">1418301_at</td><td align="left" valign="top" charoff="50">interferon regulatory factor 6</td><td align="center" valign="top" charoff="50">Irf6</td><td align="center" valign="top" charoff="50">&#x02212;3.58</td></tr><tr><td align="left" valign="top" charoff="50">1418714_at</td><td align="left" valign="top" charoff="50">dual specificity phosphatase 8</td><td align="center" valign="top" charoff="50">Dusp8</td><td align="center" valign="top" charoff="50">&#x02212;3.37</td></tr><tr><td align="left" valign="top" charoff="50">1418511_at</td><td align="left" valign="top" charoff="50">Dermatopontin</td><td align="center" valign="top" charoff="50">Dpt</td><td align="center" valign="top" charoff="50">&#x02212;3.34</td></tr><tr><td align="left" valign="top" charoff="50">1455203_at</td><td align="left" valign="top" charoff="50">RIKEN cDNA A930003A15 gene</td><td align="center" valign="top" charoff="50">A930003A15Rik</td><td align="center" valign="top" charoff="50">&#x02212;3.30</td></tr><tr><td align="left" valign="top" charoff="50">1417917_at</td><td align="left" valign="top" charoff="50">calponin 1</td><td align="center" valign="top" charoff="50">Cnn1</td><td align="center" valign="top" charoff="50">&#x02212;3.25</td></tr><tr><td colspan="4" align="center" valign="top" charoff="50">Upregulated genes</td></tr><tr><td align="left" valign="top" charoff="50">1438540_at</td><td align="left" valign="top" charoff="50">collagen, type XXV, alpha 1</td><td align="center" valign="top" charoff="50">Col25a1</td><td align="center" valign="top" charoff="50">6.51</td></tr><tr><td align="left" valign="top" charoff="50">1440085_at</td><td align="left" valign="top" charoff="50">ecto<italic>dysp</italic>lasin A2 receptor</td><td align="center" valign="top" charoff="50">Eda2r</td><td align="center" valign="top" charoff="50">5.73</td></tr><tr><td align="left" valign="top" charoff="50">1438059_at</td><td align="left" valign="top" charoff="50">cortexin 3</td><td align="center" valign="top" charoff="50">Ctxn3</td><td align="center" valign="top" charoff="50">5.23</td></tr><tr><td align="left" valign="top" charoff="50">1421698_a_at</td><td align="left" valign="top" charoff="50">collagen, type XIX, alpha 1</td><td align="center" valign="top" charoff="50">Col19a1</td><td align="center" valign="top" charoff="50">5.13</td></tr><tr><td align="left" valign="top" charoff="50">1456953_at</td><td align="left" valign="top" charoff="50">collagen, type XIX, alpha 1</td><td align="center" valign="top" charoff="50">Col19a1</td><td align="center" valign="top" charoff="50">5.11</td></tr><tr><td align="left" valign="top" charoff="50">1451203_at</td><td align="left" valign="top" charoff="50">myoglobin</td><td align="center" valign="top" charoff="50">Mb</td><td align="center" valign="top" charoff="50">4.75</td></tr><tr><td align="left" valign="top" charoff="50">1447807_s_at</td><td align="left" valign="top" charoff="50">pleckstrin homology domain containing, family H (with MyTH4 domain) member 1</td><td align="center" valign="top" charoff="50">Plekhh1</td><td align="center" valign="top" charoff="50">4.52</td></tr><tr><td align="left" valign="top" charoff="50">1422864_at</td><td align="left" valign="top" charoff="50">runt related transcription factor 1</td><td align="center" valign="top" charoff="50">Runx1</td><td align="center" valign="top" charoff="50">4.08</td></tr><tr><td align="left" valign="top" charoff="50">1422865_at</td><td align="left" valign="top" charoff="50">runt related transcription factor 1</td><td align="center" valign="top" charoff="50">Runx1</td><td align="center" valign="top" charoff="50">3.94</td></tr><tr><td align="left" valign="top" charoff="50">1418203_at</td><td align="left" valign="top" charoff="50">phorbol-12-myristate-13-acetate-induced protein 1</td><td align="center" valign="top" charoff="50">Pmaip1</td><td align="center" valign="top" charoff="50">3.69</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t2"><label>Table 2</label><caption><title>DEGs associated with signaling.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Probe Set ID</th><th align="center" valign="top" charoff="50">Gene Title</th><th align="center" valign="top" charoff="50">Gene Symbol</th><th align="center" valign="top" charoff="50">FC</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">MAPK signaling pathway</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">1418714_at</td><td align="left" valign="top" charoff="50">dual specificity phosphatase 8</td><td align="center" valign="top" charoff="50">Dusp8</td><td align="center" valign="top" charoff="50">&#x02212;3.37</td></tr><tr><td align="left" valign="top" charoff="50">1438933_x_at</td><td align="left" valign="top" charoff="50">RAS, guanyl releasing protein 2</td><td align="center" valign="top" charoff="50">Rasgrp2</td><td align="center" valign="top" charoff="50">&#x02212;2.94</td></tr><tr><td align="left" valign="top" charoff="50">1419625_at</td><td align="left" valign="top" charoff="50">heat shock protein 1-like</td><td align="center" valign="top" charoff="50">Hspa1l</td><td align="center" valign="top" charoff="50">&#x02212;2.81</td></tr><tr><td align="left" valign="top" charoff="50">1423100_at</td><td align="left" valign="top" charoff="50">FBJ osteosarcoma oncogene</td><td align="center" valign="top" charoff="50">Fos</td><td align="center" valign="top" charoff="50">&#x02212;2.43</td></tr><tr><td align="left" valign="top" charoff="50">1448694_at</td><td align="left" valign="top" charoff="50">Jun oncogene</td><td align="center" valign="top" charoff="50">Jun</td><td align="center" valign="top" charoff="50">&#x02212;2.07</td></tr><tr><td align="left" valign="top" charoff="50">1417164_at</td><td align="left" valign="top" charoff="50">dual specificity phosphatase 10</td><td align="center" valign="top" charoff="50">Dusp10</td><td align="center" valign="top" charoff="50">&#x02212;2.06</td></tr><tr><td align="left" valign="top" charoff="50">1438883_at</td><td align="left" valign="top" charoff="50">fibroblast growth factor 5</td><td align="center" valign="top" charoff="50">Fgf5</td><td align="center" valign="top" charoff="50">&#x02212;2.05</td></tr><tr><td align="left" valign="top" charoff="50">1427582_at</td><td align="left" valign="top" charoff="50">fibroblast growth factor 6</td><td align="center" valign="top" charoff="50">Fgf6</td><td align="center" valign="top" charoff="50">&#x02212;2.03</td></tr><tr><td align="left" valign="top" charoff="50">1448830_at</td><td align="left" valign="top" charoff="50">dual specificity phosphatase 1</td><td align="center" valign="top" charoff="50">Dusp1</td><td align="center" valign="top" charoff="50">&#x02212;1.95</td></tr><tr><td align="left" valign="top" charoff="50">1418401_a_at</td><td align="left" valign="top" charoff="50">dual specificity phosphatase 16</td><td align="center" valign="top" charoff="50">Dusp16</td><td align="center" valign="top" charoff="50">&#x02212;1.76</td></tr><tr><td align="left" valign="top" charoff="50">1449117_at</td><td align="left" valign="top" charoff="50">Jun proto-oncogene related gene D</td><td align="center" valign="top" charoff="50">Jund</td><td align="center" valign="top" charoff="50">&#x02212;1.75</td></tr><tr><td align="left" valign="top" charoff="50">1439205_at</td><td align="left" valign="top" charoff="50">nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 2</td><td align="center" valign="top" charoff="50">Nfatc2</td><td align="center" valign="top" charoff="50">&#x02212;1.64</td></tr><tr><td align="left" valign="top" charoff="50">1438030_at</td><td align="left" valign="top" charoff="50">RAS, guanyl releasing protein 3</td><td align="center" valign="top" charoff="50">Rasgrp3</td><td align="center" valign="top" charoff="50">&#x02212;1.63</td></tr><tr><td align="left" valign="top" charoff="50">1449773_s_at</td><td align="left" valign="top" charoff="50">growth arrest and DNA-damage-inducible 45 beta</td><td align="center" valign="top" charoff="50">Gadd45b</td><td align="center" valign="top" charoff="50">&#x02212;1.62</td></tr><tr><td align="left" valign="top" charoff="50">1435196_at</td><td align="left" valign="top" charoff="50">neurotrophic tyrosine kinase, receptor, type 2</td><td align="center" valign="top" charoff="50">Ntrk2</td><td align="center" valign="top" charoff="50">1.52</td></tr><tr><td align="left" valign="top" charoff="50">1421897_at</td><td align="left" valign="top" charoff="50">ELK1, member of ETS oncogene family</td><td align="center" valign="top" charoff="50">Elk1</td><td align="center" valign="top" charoff="50">1.56</td></tr><tr><td align="left" valign="top" charoff="50">1417856_at</td><td align="left" valign="top" charoff="50">avian reticuloendotheliosis viral (v-rel) oncogene related B</td><td align="center" valign="top" charoff="50">Relb</td><td align="center" valign="top" charoff="50">1.58</td></tr><tr><td align="left" valign="top" charoff="50">1421324_a_at</td><td align="left" valign="top" charoff="50">thymoma viral proto-oncogene 2</td><td align="center" valign="top" charoff="50">Akt2</td><td align="center" valign="top" charoff="50">1.65</td></tr><tr><td align="left" valign="top" charoff="50">1420895_at</td><td align="left" valign="top" charoff="50">transforming growth factor, beta receptor I</td><td align="center" valign="top" charoff="50">Tgfbr1</td><td align="center" valign="top" charoff="50">1.72</td></tr><tr><td align="left" valign="top" charoff="50">1440343_at</td><td align="left" valign="top" charoff="50">ribosomal protein S6 kinase, polypeptide 5</td><td align="center" valign="top" charoff="50">Rps6ka5</td><td align="center" valign="top" charoff="50">1.75</td></tr><tr><td align="left" valign="top" charoff="50">1436912_at</td><td align="left" valign="top" charoff="50">calcium channel, voltage-dependent, beta 4 subunit</td><td align="center" valign="top" charoff="50">Cacnb4</td><td align="center" valign="top" charoff="50">1.83</td></tr><tr><td colspan="4" align="center" valign="top" charoff="50">Wnt signaling pathway</td></tr><tr><td align="left" valign="top" charoff="50">1449425_at</td><td align="left" valign="top" charoff="50">wingless-related MMTV integration site 2</td><td align="center" valign="top" charoff="50">Wnt2</td><td align="center" valign="top" charoff="50">&#x02212;2.54</td></tr><tr><td align="left" valign="top" charoff="50">1423760_at</td><td align="left" valign="top" charoff="50">CD44 antigen</td><td align="center" valign="top" charoff="50">Cd44</td><td align="center" valign="top" charoff="50">&#x02212;2.29</td></tr><tr><td align="left" valign="top" charoff="50">1451031_at</td><td align="left" valign="top" charoff="50">secreted frizzled-related protein 4</td><td align="center" valign="top" charoff="50">Sfrp4</td><td align="center" valign="top" charoff="50">&#x02212;2.20</td></tr><tr><td align="left" valign="top" charoff="50">1418136_at</td><td align="left" valign="top" charoff="50">transforming growth factor beta 1 induced transcript 1</td><td align="center" valign="top" charoff="50">Tgfb1i1</td><td align="center" valign="top" charoff="50">&#x02212;1.82</td></tr><tr><td align="left" valign="top" charoff="50">1427138_at</td><td align="left" valign="top" charoff="50">coiled-coil domain containing 88C</td><td align="center" valign="top" charoff="50">Ccdc88c</td><td align="center" valign="top" charoff="50">&#x02212;1.80</td></tr><tr><td align="left" valign="top" charoff="50">1417985_at</td><td align="left" valign="top" charoff="50">Notch-regulated ankyrin repeat protein</td><td align="center" valign="top" charoff="50">Nrarp</td><td align="center" valign="top" charoff="50">&#x02212;1.72</td></tr><tr><td align="left" valign="top" charoff="50">1455689_at</td><td align="left" valign="top" charoff="50">frizzled homolog 10 (Drosophila)</td><td align="center" valign="top" charoff="50">Fzd10</td><td align="center" valign="top" charoff="50">&#x02212;1.56</td></tr><tr><td align="left" valign="top" charoff="50">1429506_at</td><td align="left" valign="top" charoff="50">naked cuticle 1 homolog (Drosophila)</td><td align="center" valign="top" charoff="50">Nkd1</td><td align="center" valign="top" charoff="50">1.53</td></tr><tr><td align="left" valign="top" charoff="50">1451689_a_at</td><td align="left" valign="top" charoff="50">SRY-box containing gene 10</td><td align="center" valign="top" charoff="50">Sox10</td><td align="center" valign="top" charoff="50">1.59</td></tr><tr><td align="left" valign="top" charoff="50">1460187_at</td><td align="left" valign="top" charoff="50">secreted frizzled-related protein 1</td><td align="center" valign="top" charoff="50">Sfrp1</td><td align="center" valign="top" charoff="50">2.36</td></tr><tr><td colspan="4" align="center" valign="top" charoff="50">PI3K and mTor signaling pathway</td></tr><tr><td align="left" valign="top" charoff="50">1451038_at</td><td align="left" valign="top" charoff="50">apelin</td><td align="center" valign="top" charoff="50">Apln</td><td align="center" valign="top" charoff="50">&#x02212;1.96</td></tr><tr><td align="left" valign="top" charoff="50">1449022_at</td><td align="left" valign="top" charoff="50">nestin</td><td align="center" valign="top" charoff="50">Nes</td><td align="center" valign="top" charoff="50">&#x02212;1.62</td></tr><tr><td align="left" valign="top" charoff="50">1421679_a_at</td><td align="left" valign="top" charoff="50">cyclin-dependent kinase inhibitor 1A (P21)</td><td align="center" valign="top" charoff="50">Cdkn1a</td><td align="center" valign="top" charoff="50">1.52</td></tr><tr><td align="left" valign="top" charoff="50">1421324_a_at</td><td align="left" valign="top" charoff="50">thymoma viral proto-oncogene 2</td><td align="center" valign="top" charoff="50">Akt2</td><td align="center" valign="top" charoff="50">1.65</td></tr><tr><td align="left" valign="top" charoff="50">1425515_at</td><td align="left" valign="top" charoff="50">phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha)</td><td align="center" valign="top" charoff="50">Pik3r1</td><td align="center" valign="top" charoff="50">1.73</td></tr><tr><td colspan="4" align="center" valign="top" charoff="50">G protein coupled signaling</td></tr><tr><td align="left" valign="top" charoff="50">1444409_at</td><td align="left" valign="top" charoff="50">rabphilin 3A-like (without C2 domains)</td><td align="center" valign="top" charoff="50">Rph3al</td><td align="center" valign="top" charoff="50">&#x02212;2.37</td></tr><tr><td align="left" valign="top" charoff="50">1417625_s_at</td><td align="left" valign="top" charoff="50">chemokine (C-X-C motif) receptor 7</td><td align="center" valign="top" charoff="50">Cxcr7</td><td align="center" valign="top" charoff="50">&#x02212;2.18</td></tr><tr><td align="left" valign="top" charoff="50">1455466_at</td><td align="left" valign="top" charoff="50">G protein-coupled receptor 133</td><td align="center" valign="top" charoff="50">Gpr133</td><td align="center" valign="top" charoff="50">&#x02212;2.10</td></tr><tr><td align="left" valign="top" charoff="50">1451038_at</td><td align="left" valign="top" charoff="50">apelin</td><td align="center" valign="top" charoff="50">Apln</td><td align="center" valign="top" charoff="50">&#x02212;1.96</td></tr><tr><td align="left" valign="top" charoff="50">1440009_at</td><td align="left" valign="top" charoff="50">olfactory receptor 78</td><td align="center" valign="top" charoff="50">Olfr78</td><td align="center" valign="top" charoff="50">&#x02212;1.81</td></tr><tr><td align="left" valign="top" charoff="50">1431326_a_at</td><td align="left" valign="top" charoff="50">tropomodulin 2</td><td align="center" valign="top" charoff="50">Tmod2</td><td align="center" valign="top" charoff="50">&#x02212;1.68</td></tr><tr><td align="left" valign="top" charoff="50">1455689_at</td><td align="left" valign="top" charoff="50">frizzled homolog 10 (Drosophila)</td><td align="center" valign="top" charoff="50">Fzd10</td><td align="center" valign="top" charoff="50">&#x02212;1.56</td></tr><tr><td align="left" valign="top" charoff="50">1418394_a_at</td><td align="left" valign="top" charoff="50">CD97 antigen</td><td align="center" valign="top" charoff="50">Cd97</td><td align="center" valign="top" charoff="50">&#x02212;1.56</td></tr><tr><td align="left" valign="top" charoff="50">1420940_x_at</td><td align="left" valign="top" charoff="50">regulator of G-protein signaling 5</td><td align="center" valign="top" charoff="50">Rgs5</td><td align="center" valign="top" charoff="50">&#x02212;1.54</td></tr><tr><td align="left" valign="top" charoff="50">1417327_at</td><td align="left" valign="top" charoff="50">caveolin 2</td><td align="center" valign="top" charoff="50">Cav2</td><td align="center" valign="top" charoff="50">&#x02212;1.53</td></tr><tr><td align="left" valign="top" charoff="50">1416286_at</td><td align="left" valign="top" charoff="50">regulator of G-protein signaling 4</td><td align="center" valign="top" charoff="50">Rgs4</td><td align="center" valign="top" charoff="50">&#x02212;1.50</td></tr><tr><td align="left" valign="top" charoff="50">1460440_at</td><td align="left" valign="top" charoff="50">latrophilin 3</td><td align="center" valign="top" charoff="50">Lphn3</td><td align="center" valign="top" charoff="50">1.62</td></tr><tr><td align="left" valign="top" charoff="50">1451411_at</td><td align="left" valign="top" charoff="50">G protein-coupled receptor, family C, group 5, member B</td><td align="center" valign="top" charoff="50">Gprc5b</td><td align="center" valign="top" charoff="50">1.63</td></tr><tr><td align="left" valign="top" charoff="50">1456833_at</td><td align="left" valign="top" charoff="50">G protein-coupled receptor 17</td><td align="center" valign="top" charoff="50">Gpr17</td><td align="center" valign="top" charoff="50">1.68</td></tr><tr><td align="left" valign="top" charoff="50">1442082_at</td><td align="left" valign="top" charoff="50">complement component 3a receptor 1</td><td align="center" valign="top" charoff="50">C3ar1</td><td align="center" valign="top" charoff="50">1.81</td></tr><tr><td align="left" valign="top" charoff="50">1436912_at</td><td align="left" valign="top" charoff="50">calcium channel, voltage-dependent, beta 4 subunit</td><td align="center" valign="top" charoff="50">Cacnb4</td><td align="center" valign="top" charoff="50">1.83</td></tr><tr><td align="left" valign="top" charoff="50">1420401_a_at</td><td align="left" valign="top" charoff="50">receptor (calcitonin) activity modifying protein 3</td><td align="center" valign="top" charoff="50">Ramp3</td><td align="center" valign="top" charoff="50">1.86</td></tr><tr><td align="left" valign="top" charoff="50">1454782_at</td><td align="left" valign="top" charoff="50">brain-specific angiogenesis inhibitor 3</td><td align="center" valign="top" charoff="50">Bai3</td><td align="center" valign="top" charoff="50">2.02</td></tr><tr><td align="left" valign="top" charoff="50">1434172_at</td><td align="left" valign="top" charoff="50">cannabinoid receptor 1 (brain)</td><td align="center" valign="top" charoff="50">Cnr1</td><td align="center" valign="top" charoff="50">2.11</td></tr><tr><td align="left" valign="top" charoff="50">1432466_a_at</td><td align="left" valign="top" charoff="50">apolipoprotein E</td><td align="center" valign="top" charoff="50">Apoe</td><td align="center" valign="top" charoff="50">2.17</td></tr><tr><td align="left" valign="top" charoff="50">1460123_at</td><td align="left" valign="top" charoff="50">G protein-coupled receptor 1</td><td align="center" valign="top" charoff="50">Gpr1</td><td align="center" valign="top" charoff="50">2.37</td></tr><tr><td align="left" valign="top" charoff="50">1450875_at</td><td align="left" valign="top" charoff="50">G protein-coupled receptor 37</td><td align="center" valign="top" charoff="50">Gpr37</td><td align="center" valign="top" charoff="50">2.54</td></tr><tr><td align="left" valign="top" charoff="50">1436889_at</td><td align="left" valign="top" charoff="50">gamma-aminobutyric acid (GABA) A receptor, subunit alpha 1</td><td align="center" valign="top" charoff="50">Gabra1</td><td align="center" valign="top" charoff="50">2.54</td></tr><tr><td colspan="4" align="center" valign="top" charoff="50">Other transcription factors and transcriptional modulators</td></tr><tr><td align="left" valign="top" charoff="50">1455267_at</td><td align="left" valign="top" charoff="50">estrogen-related receptor gamma</td><td align="center" valign="top" charoff="50">Esrrg</td><td align="center" valign="top" charoff="50">&#x02212;3.04</td></tr><tr><td align="left" valign="top" charoff="50">1449363_at</td><td align="left" valign="top" charoff="50">activating transcription factor 3</td><td align="center" valign="top" charoff="50">Atf3</td><td align="center" valign="top" charoff="50">&#x02212;2.58</td></tr><tr><td align="left" valign="top" charoff="50">1418572_x_at</td><td align="left" valign="top" charoff="50">tumor necrosis factor receptor superfamily, member 12a</td><td align="center" valign="top" charoff="50">Tnfrsf12a</td><td align="center" valign="top" charoff="50">&#x02212;2.39</td></tr><tr><td align="left" valign="top" charoff="50">1418762_at</td><td align="left" valign="top" charoff="50">CD55 antigen</td><td align="center" valign="top" charoff="50">Cd55</td><td align="center" valign="top" charoff="50">&#x02212;2.14</td></tr><tr><td align="left" valign="top" charoff="50">1425518_at</td><td align="left" valign="top" charoff="50">Rap guanine nucleotide exchange factor (GEF) 4</td><td align="center" valign="top" charoff="50">Rapgef4</td><td align="center" valign="top" charoff="50">&#x02212;1.73</td></tr><tr><td align="left" valign="top" charoff="50">1422742_at</td><td align="left" valign="top" charoff="50">human immunodeficiency virus type I enhancer binding protein 1</td><td align="center" valign="top" charoff="50">Hivep1</td><td align="center" valign="top" charoff="50">&#x02212;1.72</td></tr><tr><td align="left" valign="top" charoff="50">1420696_at</td><td align="left" valign="top" charoff="50">sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C</td><td align="center" valign="top" charoff="50">Sema3c</td><td align="center" valign="top" charoff="50">&#x02212;1.68</td></tr><tr><td align="left" valign="top" charoff="50">1456796_at</td><td align="left" valign="top" charoff="50">snail homolog 3 (Drosophila)</td><td align="center" valign="top" charoff="50">Snai3</td><td align="center" valign="top" charoff="50">&#x02212;1.66</td></tr><tr><td align="left" valign="top" charoff="50">1418936_at</td><td align="left" valign="top" charoff="50">v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian)</td><td align="center" valign="top" charoff="50">Maff</td><td align="center" valign="top" charoff="50">&#x02212;1.61</td></tr><tr><td align="left" valign="top" charoff="50">1451932_a_at</td><td align="left" valign="top" charoff="50">ADAMTS-like 4</td><td align="center" valign="top" charoff="50">Adamtsl4</td><td align="center" valign="top" charoff="50">&#x02212;1.58</td></tr><tr><td align="left" valign="top" charoff="50">1425896_a_at</td><td align="left" valign="top" charoff="50">fibrillin 1</td><td align="center" valign="top" charoff="50">Fbn1</td><td align="center" valign="top" charoff="50">&#x02212;1.57</td></tr><tr><td align="left" valign="top" charoff="50">1418394_a_at</td><td align="left" valign="top" charoff="50">CD97 antigen</td><td align="center" valign="top" charoff="50">Cd97</td><td align="center" valign="top" charoff="50">&#x02212;1.56</td></tr><tr><td align="left" valign="top" charoff="50">1459372_at</td><td align="left" valign="top" charoff="50">neuronal PAS domain protein 4</td><td align="center" valign="top" charoff="50">Npas4</td><td align="center" valign="top" charoff="50">&#x02212;1.51</td></tr><tr><td align="left" valign="top" charoff="50">1424880_at</td><td align="left" valign="top" charoff="50">tribbles homolog 1 (Drosophila)</td><td align="center" valign="top" charoff="50">Trib1</td><td align="center" valign="top" charoff="50">&#x02212;1.50</td></tr><tr><td align="left" valign="top" charoff="50">1428983_at</td><td align="left" valign="top" charoff="50">scleraxis</td><td align="center" valign="top" charoff="50">Scx</td><td align="center" valign="top" charoff="50">1.53</td></tr><tr><td align="left" valign="top" charoff="50">1429841_at</td><td align="left" valign="top" charoff="50">multiple EGF-like-domains 10</td><td align="center" valign="top" charoff="50">Megf10</td><td align="center" valign="top" charoff="50">1.53</td></tr><tr><td align="left" valign="top" charoff="50">1422210_at</td><td align="left" valign="top" charoff="50">forkhead box D3</td><td align="center" valign="top" charoff="50">Foxd3</td><td align="center" valign="top" charoff="50">1.57</td></tr><tr><td align="left" valign="top" charoff="50">1441107_at</td><td align="left" valign="top" charoff="50">doublesex and mab-3 related transcription factor like family A2</td><td align="center" valign="top" charoff="50">Dmrta2</td><td align="center" valign="top" charoff="50">1.58</td></tr><tr><td align="left" valign="top" charoff="50">1435775_at</td><td align="left" valign="top" charoff="50">circadian locomotor output cycles kaput</td><td align="center" valign="top" charoff="50">Clock</td><td align="center" valign="top" charoff="50">1.60</td></tr><tr><td align="left" valign="top" charoff="50">1457342_at</td><td align="left" valign="top" charoff="50">IKAROS family zinc finger 4</td><td align="center" valign="top" charoff="50">Ikzf4</td><td align="center" valign="top" charoff="50">1.60</td></tr><tr><td align="left" valign="top" charoff="50">1452650_at</td><td align="left" valign="top" charoff="50">tripartite motif-containing 62</td><td align="center" valign="top" charoff="50">Trim62</td><td align="center" valign="top" charoff="50">1.61</td></tr><tr><td align="left" valign="top" charoff="50">1449164_at</td><td align="left" valign="top" charoff="50">CD68 antigen</td><td align="center" valign="top" charoff="50">Cd68</td><td align="center" valign="top" charoff="50">1.61</td></tr><tr><td align="left" valign="top" charoff="50">1452021_a_at</td><td align="left" valign="top" charoff="50">hairy and enhancer of split 6</td><td align="center" valign="top" charoff="50">Hes6</td><td align="center" valign="top" charoff="50">1.66</td></tr><tr><td align="left" valign="top" charoff="50">1434458_at</td><td align="left" valign="top" charoff="50">follistatin</td><td align="center" valign="top" charoff="50">Fst</td><td align="center" valign="top" charoff="50">1.93</td></tr><tr><td align="left" valign="top" charoff="50">1450042_at</td><td align="left" valign="top" charoff="50">aristaless related homeobox</td><td align="center" valign="top" charoff="50">Arx</td><td align="center" valign="top" charoff="50">2.18</td></tr><tr><td align="left" valign="top" charoff="50">1454693_at</td><td align="left" valign="top" charoff="50">histone deacetylase 4</td><td align="center" valign="top" charoff="50">Hdac4</td><td align="center" valign="top" charoff="50">2.36</td></tr><tr><td align="left" valign="top" charoff="50">1418937_at</td><td align="left" valign="top" charoff="50">deiodinase, iodothyronine, type II</td><td align="center" valign="top" charoff="50">Dio2</td><td align="center" valign="top" charoff="50">2.87</td></tr><tr><td align="left" valign="top" charoff="50">1422864_at</td><td align="left" valign="top" charoff="50">runt related transcription factor 1</td><td align="center" valign="top" charoff="50">Runx1</td><td align="center" valign="top" charoff="50">4.08</td></tr><tr><td align="left" valign="top" charoff="50">1440085_at</td><td align="left" valign="top" charoff="50">ecto<italic>dysp</italic>lasin A2 receptor</td><td align="center" valign="top" charoff="50">Eda2r</td><td align="center" valign="top" charoff="50">5.73</td></tr></tbody></table></table-wrap><table-wrap position="float" id="t3"><label>Table 3</label><caption><title>Muscle organ-related DEGs associated with muscle contraction and mechanical force production.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="left"/><col align="center"/><col align="center"/><col align="left"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Muscle organ related differentially regulated in <italic>dysp</italic></th><th align="left" valign="top" charoff="50">&#x000a0;</th><th colspan="3" align="left" valign="top" charoff="50">&#x000a0;</th></tr><tr><th align="left" valign="top" charoff="50">(a) Muscle contraction/ mechanical force</th><th align="left" valign="top" charoff="50">&#x000a0;</th><th colspan="3" align="left" valign="top" charoff="50">&#x000a0;</th></tr><tr><th align="left" valign="top" charoff="50">Probe Set ID</th><th align="left" valign="top" charoff="50">Gene Title</th><th align="center" valign="top" charoff="50">Gene Symbol</th><th align="center" valign="top" charoff="50">Fold Change</th><th align="left" valign="top" charoff="50">Localization/Function</th></tr></thead><tbody valign="top"><tr><td align="left" valign="top" charoff="50">1448394_at</td><td align="left" valign="top" charoff="50">myosin, light polypeptide 2, regulatory, cardiac, slow</td><td align="center" valign="top" charoff="50">Myl2</td><td align="center" valign="top" charoff="50">&#x02212;10.85</td><td align="left" valign="top" charoff="50">Sarcomere, part of myosin filaments</td></tr><tr><td align="left" valign="top" charoff="50">1419145_at</td><td align="left" valign="top" charoff="50">smoothelin-like 1</td><td align="center" valign="top" charoff="50">Smtnl1</td><td align="center" valign="top" charoff="50">&#x02212;9.68</td><td align="left" valign="top" charoff="50">Sarcomere, binds calmodulin and tropomyosin <sup>S1</sup></td></tr><tr><td align="left" valign="top" charoff="50">1417917_at</td><td align="left" valign="top" charoff="50">calponin 1</td><td align="center" valign="top" charoff="50">Cnn1</td><td align="center" valign="top" charoff="50">&#x02212;3.25</td><td align="left" valign="top" charoff="50">Sarcomere; binds tropomyosin and inhibits cross-bridge cycle in a Ca2+ dependent manner <sup>S2</sup></td></tr><tr><td align="left" valign="top" charoff="50">1449996_a_at</td><td align="left" valign="top" charoff="50">tropomyosin 3, gamma</td><td align="center" valign="top" charoff="50">Tpm3</td><td align="center" valign="top" charoff="50">&#x02212;3.24</td><td align="left" valign="top" charoff="50">Sarcomere, Actin filament associated</td></tr><tr><td align="left" valign="top" charoff="50">1420991_at</td><td align="left" valign="top" charoff="50">ankyrin repeat domain 1 (cardiac muscle)</td><td align="center" valign="top" charoff="50">Ankrd1</td><td align="center" valign="top" charoff="50">&#x02212;2.99</td><td align="left" valign="top" charoff="50">Sarcomere, Z-disc, Part of titin-N2A mechanosensory complex <sup>S3</sup></td></tr><tr><td align="left" valign="top" charoff="50">1427768_s_at</td><td align="left" valign="top" charoff="50">myosin, light polypeptide 3</td><td align="center" valign="top" charoff="50">Myl3</td><td align="center" valign="top" charoff="50">&#x02212;2.93</td><td align="left" valign="top" charoff="50">Sarcomere, part of myosin filaments</td></tr><tr><td align="left" valign="top" charoff="50">1439204_at</td><td align="left" valign="top" charoff="50">sodium channel, voltage-gated, type III, alpha</td><td align="center" valign="top" charoff="50">Scn3a</td><td align="center" valign="top" charoff="50">&#x02212;2.93</td><td align="left" valign="top" charoff="50">Sarcolemma, Sodium channel</td></tr><tr><td align="left" valign="top" charoff="50">1452670_at</td><td align="left" valign="top" charoff="50">myosin, light polypeptide 9, regulatory</td><td align="center" valign="top" charoff="50">Myl9</td><td align="center" valign="top" charoff="50">&#x02212;2.65</td><td align="left" valign="top" charoff="50">Sarcomere, part of myosin filaments</td></tr><tr><td align="left" valign="top" charoff="50">1420647_a_at</td><td align="left" valign="top" charoff="50">keratin 8</td><td align="center" valign="top" charoff="50">Krt8</td><td align="center" valign="top" charoff="50">&#x02212;2.58</td><td align="left" valign="top" charoff="50">Sacomere; Z-disc and M-line domains at costameres at the sarcolemmal membrane <sup>S4</sup></td></tr><tr><td align="left" valign="top" charoff="50">1421253_at</td><td align="left" valign="top" charoff="50">nebulin-related anchoring protein</td><td align="center" valign="top" charoff="50">Nrap</td><td align="center" valign="top" charoff="50">&#x02212;2.41</td><td align="left" valign="top" charoff="50">Sarcomere; Z-disc; terminal actin binding</td></tr><tr><td align="left" valign="top" charoff="50">1460318_at</td><td align="left" valign="top" charoff="50">cysteine and glycine-rich protein 3</td><td align="center" valign="top" charoff="50">Csrp3</td><td align="center" valign="top" charoff="50">&#x02212;2.37</td><td align="left" valign="top" charoff="50">Sarcomere; Z-disc</td></tr><tr><td align="left" valign="top" charoff="50">1416554_at</td><td align="left" valign="top" charoff="50">PDZ and LIM domain 1 (elfin)</td><td align="center" valign="top" charoff="50">Pdlim1</td><td align="center" valign="top" charoff="50">&#x02212;2.31</td><td align="left" valign="top" charoff="50">Sarcomere; Z-disc; Interaction with &#x003b1;-actinin</td></tr><tr><td align="left" valign="top" charoff="50">1435767_at</td><td align="left" valign="top" charoff="50">sodium channel, voltage-gated, type III, beta</td><td align="center" valign="top" charoff="50">Scn3b</td><td align="center" valign="top" charoff="50">&#x02212;2.23</td><td align="left" valign="top" charoff="50">Sarcolemma, Sodium channel</td></tr><tr><td align="left" valign="top" charoff="50">1417872_at</td><td align="left" valign="top" charoff="50">four and a half LIM domains 1</td><td align="center" valign="top" charoff="50">Fhl1</td><td align="center" valign="top" charoff="50">&#x02212;1.94</td><td align="left" valign="top" charoff="50">Sarcomere, Z-disc <sup>S5</sup></td></tr><tr><td align="left" valign="top" charoff="50">1416326_at</td><td align="left" valign="top" charoff="50">cysteine-rich protein 1 (intestinal)</td><td align="center" valign="top" charoff="50">Crip1</td><td align="center" valign="top" charoff="50">&#x02212;1.76</td><td align="left" valign="top" charoff="50">Sarcomere, Z-disc; Interaction with &#x003b1;-actinin <sup>S5</sup></td></tr><tr><td align="left" valign="top" charoff="50">1422635_at</td><td align="left" valign="top" charoff="50">acetylcholinesterase</td><td align="center" valign="top" charoff="50">Ache</td><td align="center" valign="top" charoff="50">&#x02212;1.71</td><td align="left" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">1450650_at</td><td align="left" valign="top" charoff="50">myosin X</td><td align="center" valign="top" charoff="50">Myo10</td><td align="center" valign="top" charoff="50">1.57</td><td align="left" valign="top" charoff="50">Link between integrins and cytoskeleton <sup>S6</sup></td></tr><tr><td align="left" valign="top" charoff="50">1424967_x_at</td><td align="left" valign="top" charoff="50">troponin T2, cardiac</td><td align="center" valign="top" charoff="50">Tnnt2</td><td align="center" valign="top" charoff="50">1.59</td><td align="left" valign="top" charoff="50">Sarcomere; interaction with tropomyosin of actin filaments</td></tr><tr><td align="left" valign="top" charoff="50">1449307_at</td><td align="left" valign="top" charoff="50">dysbindin (dystrobrevin binding protein 1) domain containing 1</td><td align="center" valign="top" charoff="50">Dbndd1</td><td align="center" valign="top" charoff="50">1.75</td><td align="left" valign="top" charoff="50">costameres, part of dystrophin-glycoprotein complex (DGC) <sup>S7</sup></td></tr><tr><td align="left" valign="top" charoff="50">1436912_at</td><td align="left" valign="top" charoff="50">calcium channel, voltage-dependent, beta 4 subunit</td><td align="center" valign="top" charoff="50">Cacnb4</td><td align="center" valign="top" charoff="50">1.83</td><td align="left" valign="top" charoff="50">neuronal Calcium channel subunit; able to associate with Ca<sub>v</sub>1.1 of skeletal muscle</td></tr><tr><td align="left" valign="top" charoff="50">1418852_at</td><td align="left" valign="top" charoff="50">cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle)</td><td align="center" valign="top" charoff="50">Chrna1</td><td align="center" valign="top" charoff="50">2.28</td><td align="left" valign="top" charoff="50">Neuromuscular junctions; muscle excitation</td></tr><tr><td align="left" valign="top" charoff="50">(b) Structure and Morphogenesis</td><td align="left" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="center" valign="top" charoff="50">&#x000a0;</td><td align="left" valign="top" charoff="50">&#x000a0;</td></tr><tr><td align="left" valign="top" charoff="50">Probe Set ID</td><td align="left" valign="top" charoff="50">Gene Title</td><td align="center" valign="top" charoff="50">Gene Symbol</td><td align="center" valign="top" charoff="50">Fold Change</td><td align="left" valign="top" charoff="50">Localization/Function</td></tr><tr><td align="left" valign="top" charoff="50">1418511_at</td><td align="left" valign="top" charoff="50">dermatopontin</td><td align="center" valign="top" charoff="50">Dpt</td><td align="center" valign="top" charoff="50">&#x02212;3.34</td><td align="left" valign="top" charoff="50">cell-matrix adhesion <sup>S8</sup></td></tr><tr><td align="left" valign="top" charoff="50">1449082_at</td><td align="left" valign="top" charoff="50">microfibrillar associated protein 5</td><td align="center" valign="top" charoff="50">Mfap5</td><td align="center" valign="top" charoff="50">&#x02212;3.13</td><td align="left" valign="top" charoff="50">ECM; glycoprotein associated with microbibrils like elastine <sup>S9</sup></td></tr><tr><td align="left" valign="top" charoff="50">1450798_at</td><td align="left" valign="top" charoff="50">tenascin XB</td><td align="center" valign="top" charoff="50">Tnxb</td><td align="center" valign="top" charoff="50">&#x02212;2.85</td><td align="left" valign="top" charoff="50">ECM; collagen formation <sup>S10</sup></td></tr><tr><td align="left" valign="top" charoff="50">1456344_at</td><td align="left" valign="top" charoff="50">tenascin C</td><td align="center" valign="top" charoff="50">Tnc</td><td align="center" valign="top" charoff="50">&#x02212;2.63</td><td align="left" valign="top" charoff="50">ECM; glycoprotein; interaction with fibronectin <sup>S11</sup></td></tr><tr><td align="left" valign="top" charoff="50">1416697_at</td><td align="left" valign="top" charoff="50">dipeptidylpeptidase 4</td><td align="center" valign="top" charoff="50">Dpp4</td><td align="center" valign="top" charoff="50">&#x02212;2.25</td><td align="left" valign="top" charoff="50">cell surface peptidase; cell-cell connections <sup>S12</sup></td></tr><tr><td align="left" valign="top" charoff="50">1424701_at</td><td align="left" valign="top" charoff="50">protocadherin 20</td><td align="center" valign="top" charoff="50">Pcdh20</td><td align="center" valign="top" charoff="50">&#x02212;2.35</td><td align="left" valign="top" charoff="50">Transmembrane protein, cell-cell connentions</td></tr><tr><td align="left" valign="top" charoff="50">1423760_at</td><td align="left" valign="top" charoff="50">CD44 antigen</td><td align="center" valign="top" charoff="50">Cd44</td><td align="center" valign="top" charoff="50">&#x02212;2.29</td><td align="left" valign="top" charoff="50">Cell surface glycoprotein; migration and myoblast fusion <sup>S13</sup></td></tr><tr><td align="left" valign="top" charoff="50">1449388_at</td><td align="left" valign="top" charoff="50">thrombospondin 4</td><td align="center" valign="top" charoff="50">Thbs4</td><td align="center" valign="top" charoff="50">&#x02212;2.14</td><td align="left" valign="top" charoff="50">ECM glycoprotein</td></tr><tr><td align="left" valign="top" charoff="50">1426529_a_at</td><td align="left" valign="top" charoff="50">transgelin 2</td><td align="center" valign="top" charoff="50">Tagln2</td><td align="center" valign="top" charoff="50">&#x02212;1.93</td><td align="left" valign="top" charoff="50">Cytoskeleton; Actin-gelling protein <sup>S14</sup></td></tr><tr><td align="left" valign="top" charoff="50">1437218_at</td><td align="left" valign="top" charoff="50">fibronectin 1</td><td align="center" valign="top" charoff="50">Fn1</td><td align="center" valign="top" charoff="50">&#x02212;1.74</td><td align="left" valign="top" charoff="50">ECM glycoprotein, cell adhesion</td></tr><tr><td align="left" valign="top" charoff="50">1434928_at</td><td align="left" valign="top" charoff="50">growth arrest-specific 2 like 1</td><td align="center" valign="top" charoff="50">Gas2l1</td><td align="center" valign="top" charoff="50">&#x02212;1.72</td><td align="left" valign="top" charoff="50">Cytoskeletaon; Crosslinking of microfilaments and microtubules <xref ref-type="bibr" rid="b15">15</xref></td></tr><tr><td align="left" valign="top" charoff="50">1449022_at</td><td align="left" valign="top" charoff="50">nestin</td><td align="center" valign="top" charoff="50">Nes</td><td align="center" valign="top" charoff="50">&#x02212;1.62</td><td align="left" valign="top" charoff="50">Cytoskeleton, intermediate filament, colocalized with desmin in Z-disc of embryonic skeletal muscle <sup>S16</sup></td></tr><tr><td align="left" valign="top" charoff="50">1451932_a_at</td><td align="left" valign="top" charoff="50">ADAMTS-like 4</td><td align="center" valign="top" charoff="50">Adamtsl4</td><td align="center" valign="top" charoff="50">&#x02212;1.58</td><td align="left" valign="top" charoff="50">ECM; glycoprotein; microfibril biogenesis <sup>S17</sup></td></tr><tr><td align="left" valign="top" charoff="50">1425896_a_at</td><td align="left" valign="top" charoff="50">fibrillin 1</td><td align="center" valign="top" charoff="50">Fbn1</td><td align="center" valign="top" charoff="50">&#x02212;1.57</td><td align="left" valign="top" charoff="50">ECM glycoprotein</td></tr><tr><td align="left" valign="top" charoff="50">1436425_at</td><td align="left" valign="top" charoff="50">KN motif and ankyrin repeat domains 4</td><td align="center" valign="top" charoff="50">Kank4</td><td align="center" valign="top" charoff="50">1.56</td><td align="left" valign="top" charoff="50">Control of actin-polymerization <sup>S18</sup></td></tr><tr><td align="left" valign="top" charoff="50">1434709_at</td><td align="left" valign="top" charoff="50">neuron-glia-CAM-related cell adhesion molecule</td><td align="center" valign="top" charoff="50">Nrcam</td><td align="center" valign="top" charoff="50">1.64</td><td align="left" valign="top" charoff="50">Transmembrane cell adhesion protein; axon guidance <sup>S19</sup></td></tr><tr><td align="left" valign="top" charoff="50">1418204_s_at</td><td align="left" valign="top" charoff="50">allograft inflammatory factor 1</td><td align="center" valign="top" charoff="50">Aif1</td><td align="center" valign="top" charoff="50">1.68</td><td align="left" valign="top" charoff="50">Actin-polymerizing protein <sup>S20</sup></td></tr><tr><td align="left" valign="top" charoff="50">1419050_at</td><td align="left" valign="top" charoff="50">transmembrane protein 8C</td><td align="center" valign="top" charoff="50">Tmem8c</td><td align="center" valign="top" charoff="50">1.74</td><td align="left" valign="top" charoff="50">Transmembrane cell surface protein, myoblast fusion <sup>S21</sup></td></tr><tr><td align="left" valign="top" charoff="50">1429861_at</td><td align="left" valign="top" charoff="50">protocadherin 9</td><td align="center" valign="top" charoff="50">Pcdh9</td><td align="center" valign="top" charoff="50">1.90</td><td align="left" valign="top" charoff="50">Transmembrane protein, cell-cell connentions</td></tr><tr><td align="left" valign="top" charoff="50">1418139_at</td><td align="left" valign="top" charoff="50">doublecortin</td><td align="center" valign="top" charoff="50">Dcx</td><td align="center" valign="top" charoff="50">2.03</td><td align="left" valign="top" charoff="50">Marker for Pax7+MyoD&#x02212; subpopulation contributing to myofiber maturation during muscle regeneration <sup>S22</sup></td></tr><tr><td align="left" valign="top" charoff="50">1456953_at</td><td align="left" valign="top" charoff="50">collagen, type XIX, alpha 1</td><td align="center" valign="top" charoff="50">Col19a1</td><td align="center" valign="top" charoff="50">5.11</td><td align="left" valign="top" charoff="50">ECM, expressed during muscle development <sup>S23</sup></td></tr><tr><td align="left" valign="top" charoff="50">1438540_at</td><td align="left" valign="top" charoff="50">collagen, type XXV, alpha 1</td><td align="center" valign="top" charoff="50">Col25a1</td><td align="center" valign="top" charoff="50">6.51</td><td align="left" valign="top" charoff="50">ECM, branching of axon bundles within the muscle <sup>S24</sup></td></tr></tbody></table><table-wrap-foot><fn id="t3-fn1"><p>(<bold>a</bold>), and muscle structure/morphogenesis (<bold>b</bold>). Corresponding references are given in <xref ref-type="supplementary-material" rid="S1">Supplementary Table S3</xref>.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t4"><label>Table 4</label><caption><title>Primer sequences and amplicon size used for qRT-PCR.</title></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="left"/><col align="center"/><col align="center"/></colgroup><thead valign="bottom"><tr><th align="left" valign="top" charoff="50">Gene</th><th align="center" valign="top" charoff="50">Primers (5&#x02032; to 3&#x02032;)</th><th align="center" valign="top" charoff="50">Amplicon (bp)</th></tr></thead><tbody valign="top"><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Bai3</italic></td><td align="center" valign="top" charoff="50">Fwd: AGTATGGAGGAAGGCCCTGT</td><td rowspan="2" align="center" valign="middle" charoff="50">107</td></tr><tr><td align="center" valign="top" charoff="50">Rev: GTGGCTCCATGAACTCCATT</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Col19a1</italic></td><td align="center" valign="top" charoff="50">Fwd: TTGGATTGCCAGGAGAACAT</td><td rowspan="2" align="center" valign="middle" charoff="50">114</td></tr><tr><td align="center" valign="top" charoff="50">Rev: CAGCATCACCCTTCAGACCT</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Flcn</italic></td><td align="center" valign="top" charoff="50">Fwd: GCTGGGATTACCGAACTGAG</td><td rowspan="2" align="center" valign="middle" charoff="50">110</td></tr><tr><td align="center" valign="top" charoff="50">Rev: AGGCGATCTGTCGTAACACC</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Fos</italic></td><td align="center" valign="top" charoff="50">Fwd: AGTCAAGGCCTGGTCTGTGT</td><td rowspan="2" align="center" valign="middle" charoff="50">100</td></tr><tr><td align="center" valign="top" charoff="50">Rev: TCCAGCACCAGGTTAATTCC</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Gapdh</italic></td><td align="center" valign="top" charoff="50">Fwd: AGTGTTTCCTCGTCCCGTAG</td><td rowspan="2" align="center" valign="middle" charoff="50">119</td></tr><tr><td align="center" valign="top" charoff="50">Rev: TGATGGCAACAATCTCCACT</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Jun</italic></td><td align="center" valign="top" charoff="50">Fwd: GAAAAGTAGCCCCCAACCTC</td><td rowspan="2" align="center" valign="middle" charoff="50">106</td></tr><tr><td align="center" valign="top" charoff="50">Rev: ACAGGGGACACAGCTTTCAC</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Mrf4</italic></td><td align="center" valign="top" charoff="50">Fwd: GCAGAGGGCTCTCCTTTGTA</td><td rowspan="2" align="center" valign="middle" charoff="50">105</td></tr><tr><td align="center" valign="top" charoff="50">Rev: AACGTGTTCCTCTCCACTGC</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Myf5</italic></td><td align="center" valign="top" charoff="50">Fwd: GAAGGTCAACCAAGCTTTCG</td><td rowspan="2" align="center" valign="middle" charoff="50">109</td></tr><tr><td align="center" valign="top" charoff="50">Rev: GCTCTCAATGTAGCGGATGG</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Myl2</italic></td><td align="center" valign="top" charoff="50">Fwd: AAAGAGGCTCCAGGTCCAAT</td><td rowspan="2" align="center" valign="middle" charoff="50">105</td></tr><tr><td align="center" valign="top" charoff="50">Rev: CACCTTGAATGCGTTGAGAA</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Myod</italic></td><td align="center" valign="top" charoff="50">Fwd: GGCTACGACACCGCCTACTA</td><td rowspan="2" align="center" valign="middle" charoff="50">110</td></tr><tr><td align="center" valign="top" charoff="50">Rev: GTGGAGATGCGCTCCACTAT</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Myog</italic></td><td align="center" valign="top" charoff="50">Fwd: CTGCACTCCCTTACGTCCAT</td><td rowspan="2" align="center" valign="middle" charoff="50">103</td></tr><tr><td align="center" valign="top" charoff="50">Rev: CCCAGCCTGACAGACAATCT</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Pax3</italic></td><td align="center" valign="top" charoff="50">Fwd: AAACCCAAGCAGGTGACAAC</td><td rowspan="2" align="center" valign="middle" charoff="50">115</td></tr><tr><td align="center" valign="top" charoff="50">Rev: AGACAGCGTCCTTGAGCAAT</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Pax7</italic></td><td align="center" valign="top" charoff="50">Fwd: ATTACCTGGCCAAAAACGTG</td><td rowspan="2" align="center" valign="middle" charoff="50">105</td></tr><tr><td align="center" valign="top" charoff="50">Rev: AGTAGGCTTGTCCCGTTTCC</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Six1</italic></td><td align="center" valign="top" charoff="50">Fwd: CCTGGGGCAAAATGATGTAT</td><td rowspan="2" align="center" valign="middle" charoff="50">112</td></tr><tr><td align="center" valign="top" charoff="50">Rev: CAAAGCATGAGCAAGCCAAC</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Six4</italic></td><td align="center" valign="top" charoff="50">Fwd: GGCCAGAGGTTGTTGTTTGT</td><td rowspan="2" align="center" valign="middle" charoff="50">109</td></tr><tr><td align="center" valign="top" charoff="50">Rev: GGCAGCCAAGCTGTGTAAGT</td></tr><tr><td rowspan="2" align="left" valign="middle" charoff="50"><italic>Trib1</italic></td><td align="center" valign="top" charoff="50">Fwd: TAACAAACTCCCCCTTGCTG</td><td rowspan="2" align="center" valign="middle" charoff="50">105</td></tr><tr><td align="center" valign="top" charoff="50">Rev: CAACGCAGAACAGTCATGGT</td></tr></tbody></table></table-wrap></floats-group></article>